<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucsdsom_pharm_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucsdsom_pharm_oapdeposits items</title>
    <link>https://escholarship.org/uc/ucsdsom_pharm_oapdeposits/rss</link>
    <description>Recent eScholarship items from Department of Pharmacology - Open Access Policy Deposits</description>
    <pubDate>Thu, 6 Aug 2026 11:14:38 +0000</pubDate>
    <item>
      <title>The R120G Knock-in Mutation in αB-Crystallin is Insufficient to Induce Cardiomyopathy in Mice</title>
      <link>https://escholarship.org/uc/item/90f8t0ng</link>
      <description>Alpha B-crystallin (CryAB) is a small heat-shock protein highly expressed in cardiac tissue, where it functions as a molecular chaperone that helps prevent protein aggregation, particularly under stress conditions. A missense mutation in CryAB (R120G) causes autosomal dominant cardiomyopathy in humans and is characterized by extensive protein aggregation in cardiomyocytes. To better understand the pathogenic mechanisms underlying CryAB&lt;sup&gt;R120G&lt;/sup&gt;-associated cardiomyopathy, appropriate in vivo models are essential. Genetic mouse models are valuable tools for investigating disease pathogenesis and evaluating potential therapeutic strategies. In this study, we characterized a homozygous CryAB&lt;sup&gt;R120G&lt;/sup&gt; knock-in (KI) mouse model to assess the impact of this mutation on cardiac function. CryAB&lt;sup&gt;R120G&lt;/sup&gt; KI mice exhibited no overt changes in cardiac structure and function up to 12 months of age, with minimal changes in cardiac and proteotoxic stress markers, except...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/90f8t0ng</guid>
      <pubDate>Thu, 16 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Quiles, Justin M</name>
      </author>
      <author>
        <name>Ravindran, Rishith</name>
      </author>
      <author>
        <name>Ivezich, Samantha</name>
      </author>
      <author>
        <name>Chi, Liguo</name>
      </author>
      <author>
        <name>Najor, Rita</name>
      </author>
      <author>
        <name>Gustafsson, Åsa B</name>
      </author>
    </item>
    <item>
      <title>A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit</title>
      <link>https://escholarship.org/uc/item/1rj4n5wm</link>
      <description>The structure of the catalytic subunit of cAMP-dependent protein kinase (PKA-C), a prototype for the protein kinase superfamily, laid the foundation for the development of targeted kinase inhibitors. Here we describe the structure and biophysical characterization of a PKA-C complex with BLU0588, a small PKA-selective inhibitor. The high-resolution crystal structure not only captures the inhibitor's unusual T-shaped geometry, but also shows how the four rings of BLU0588 serve as surrogates for ATP's adenosine and phosphate-organizing sites. Each site contains two subsites. BLU0588's planar azaindole and pyridine rings, which are buried beneath the glycine-rich loop in a hydrophobic shell at the base of the active site cleft, fill the adenine and ribose subsites. In contrast, BLU0588's indane and pyrrolidine rings fill the phosphate-organizing site. The indane ring occupies the α/β-phosphate organizing site while the pyrrolidine ring fills the Mg/γ-phosphate organizing site. The...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rj4n5wm</guid>
      <pubDate>Wed, 15 Jul 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bruystens, Jessica GH</name>
      </author>
      <author>
        <name>Wu, Jian</name>
        <uri>https://orcid.org/0000-0002-8031-9462</uri>
      </author>
      <author>
        <name>Tan, Gerald</name>
      </author>
      <author>
        <name>Bertinetti, Daniela</name>
      </author>
      <author>
        <name>Zenn, Hans-Michael</name>
      </author>
      <author>
        <name>Zimmermann, Bastian</name>
      </author>
      <author>
        <name>Chen, Lisa</name>
      </author>
      <author>
        <name>Köckenberger, Johannes</name>
      </author>
      <author>
        <name>Massaro, Federica</name>
      </author>
      <author>
        <name>Sankaran, Banumathi</name>
      </author>
      <author>
        <name>Walters, Matthew S</name>
      </author>
      <author>
        <name>Veglia, Gianluigi</name>
      </author>
      <author>
        <name>Ferguson, Fleur M</name>
        <uri>https://orcid.org/0000-0003-4091-7617</uri>
      </author>
      <author>
        <name>Herberg, Friedrich W</name>
      </author>
      <author>
        <name>Taylor, Susan S</name>
      </author>
    </item>
    <item>
      <title>Coupling of cargo to the autophagy receptor is a critical step in ER-phagy.</title>
      <link>https://escholarship.org/uc/item/81s3h6k2</link>
      <description>During cell stress, endoplasmic reticulum autophagy (ER-phagy) receptors remodel the ER by sequestering membrane proteins (cargo) into autophagosomes for degradation. The conserved ER-phagy receptor, Atg40, contains a motif that binds to Atg8 and a reticulon homology domain that is needed for vacuolar/lysosomal delivery. Cargo capture, however, requires the Atg40 binding partner Lst1/SEC24C. To address whether lipids regulate cargo capture during ER-phagy, we analyzed autophagy in neutral lipid-deficient cells. Unexpectedly, we found that Atg40 was delivered to the vacuole in autophagosomes without Lst1/SEC24C or cargo in mutant cells. Lipidomic analysis revealed changes in the ratio of phosphatidylethanolamine to phosphatidylcholine in the neutral lipid-deficient cells that are predicted to alter ER membrane bendability. Our findings imply that phospholipids control cargo sequestration by regulating receptor-cargo coupling at autophagic sites.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/81s3h6k2</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Shuliang</name>
      </author>
      <author>
        <name>Banerjee, Subhrajit</name>
      </author>
      <author>
        <name>Liu, Dongmei</name>
      </author>
      <author>
        <name>Kumar, Kamal</name>
      </author>
      <author>
        <name>Obara, Christopher</name>
      </author>
      <author>
        <name>Novick, Peter</name>
      </author>
      <author>
        <name>Prinz, William</name>
      </author>
      <author>
        <name>Ferro-Novick, Susan</name>
      </author>
    </item>
    <item>
      <title>Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes</title>
      <link>https://escholarship.org/uc/item/6m40k0gc</link>
      <description>INTRODUCTION: Metformin may be associated with reduced colorectal cancer (CRC) risk, but findings from previous studies have been inconsistent and had insufficient sample sizes to examine whether the association differs by anatomic site. This study examined whether metformin was associated with reduced CRC risk, both overall and stratified by anatomic site, in a large sample of persons with diabetes who underwent colonoscopy.
METHODS: We performed a case-control study of US Veterans with prevalent diabetes who underwent colonoscopy between 1999 and 2014 using Department of Veterans Affairs electronic health record data. Cases were defined by presence of CRC at colonoscopy, while controls had normal colonoscopy. The primary exposure was metformin use at time of colonoscopy (yes/no). Association of metformin exposure with CRC (further stratified by proximal, distal, or rectal subsite) was examined using multivariable and multinomial logistic regression and summarized by odds ratios...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6m40k0gc</guid>
      <pubDate>Wed, 17 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Demb, Joshua</name>
      </author>
      <author>
        <name>Yaseyyedi, Armaan</name>
      </author>
      <author>
        <name>Liu, Lin</name>
      </author>
      <author>
        <name>Bustamante, Ranier</name>
      </author>
      <author>
        <name>Earles, Ashley</name>
      </author>
      <author>
        <name>Ghosh, Pradipta</name>
        <uri>https://orcid.org/0000-0002-8917-3201</uri>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Gawron, Andrew J</name>
      </author>
      <author>
        <name>Kaltenbach, Tonya R</name>
      </author>
      <author>
        <name>Martinez, Maria Elena</name>
      </author>
      <author>
        <name>Gupta, Samir</name>
        <uri>https://orcid.org/0000-0003-4192-5002</uri>
      </author>
    </item>
    <item>
      <title>Abstract 1837: Targeting Hippo/YAP-TEAD increases the antitumor activity of darovasertib in uveal melanoma.</title>
      <link>https://escholarship.org/uc/item/03q8469g</link>
      <description>Abstract Activating mutations in GNAQ and GNA11 (GNAQ oncogenes) are found in ∼93% of uveal melanoma (UVM) and 4% of skin cutaneous melanoma (SKCM), where they act as driver oncogenes. UVM is the most common primary cancer of the eye in adults, affecting more than 2,500 patients each year in the US alone, nearly 50% of whom will die from liver metastasis. To date, there are limited effective therapeutic options to prevent or treat UVM metastatic disease (mUVM), which typically also fails to respond to immunotherapies. By combining synthetic biology approaches, CRISPR/Cas9 genome-wide screens, and high-throughput chemogenetic drug screening, our team has revealed that classical and novel non-canonical GNAQ signaling circuits converge to promote UVM growth, survival, metastasis, and treatment resistance. Ultimately, elucidating GNAQ oncogenic signaling networks may reveal system vulnerabilities that can be exploited to develop new precision therapies for mUVM. In this regard, we...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/03q8469g</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cervantes-Villagrana, Rodolfo Daniel</name>
      </author>
      <author>
        <name>Cardenas Alcoser, Elena Sofia</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
      </author>
      <author>
        <name>Lubrano, Simone</name>
      </author>
      <author>
        <name>Ishikawa, Tomohiko</name>
      </author>
      <author>
        <name>Aplin, Andrew E</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
      </author>
    </item>
    <item>
      <title>Interplay between cortical adhesion and membrane bending regulates the formation of microparticles</title>
      <link>https://escholarship.org/uc/item/0j31s3xn</link>
      <description>Cells release vesicles that serve important roles in long-range signaling and intercellular communication. These vesicles are released not just in response to stress, inflammation, injury, and chemoresistance, but also during...
Cells release vesicles that serve important roles in long-range signaling and intercellular communication. These vesicles are released not just in response to stress, inflammation, injury, and chemoresistance, but also during homeostatic regulation. A particular class of vesicles called ectosomes or microparticles are released by the outward budding of the plasma membrane, a process which requires both the detachment of the membrane from the cortex and the exposure of negatively charged, curvature-inducing lipids such as phosphatidylserine from the inner leaflet to the outer leaflet. In this work, we develop a biophysical model that accounts for the interaction between these different factors. Using our model, we predict how linker properties influence...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0j31s3xn</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mahapatra, Arijit</name>
      </author>
      <author>
        <name>Malingen, Sage</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
        <uri>https://orcid.org/0000-0001-5953-4347</uri>
      </author>
    </item>
    <item>
      <title>Assessing Recruitment Strategies for Creating an Inclusive Tenure Track Faculty in Health Sciences: A Cohort Study</title>
      <link>https://escholarship.org/uc/item/9xz8f0t3</link>
      <description>Assessing Recruitment Strategies for Creating an Inclusive Tenure Track Faculty in Health Sciences: A Cohort Study</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9xz8f0t3</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Corr, Maripat</name>
      </author>
      <author>
        <name>Reznik, Vivian</name>
      </author>
      <author>
        <name>Wingard, Deborah</name>
      </author>
      <author>
        <name>Fettes, Danielle</name>
      </author>
      <author>
        <name>Hazen, Virginia</name>
      </author>
      <author>
        <name>Martinez, Maria Elena</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
    </item>
    <item>
      <title>Risk factors associated with return sepsis admission following emergency department discharge with infection</title>
      <link>https://escholarship.org/uc/item/7kg3m3fz</link>
      <description>INTRODUCTION: Despite sepsis having growing awareness nationally, efforts to reduce the public health impact of sepsis have lagged. Although there are known pathophysiologic mechanisms and preventive strategies, sepsis is rarely approached as a predictable or preventable condition. Predicting who will develop sepsis in patients with infection still remains a challenge. This study examined modifiable and nonmodifiable risk factors associated with patients initially discharged home with an infection and had future sepsis-related admissions within 7&amp;nbsp;days of the index Emergency Department (ED) visit.
METHODS: We conducted a multi-center retrospective cohort analysis of adults presenting to two university hospital EDs. The inclusion criteria encompassed adult patients who were discharged from the ED at their index visit with discharge diagnosis (ICD 10-CM code) of pneumonia, urinary tract infection (UTI), and/or cellulitis and who returned for hospital admission within 7&amp;nbsp;days...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7kg3m3fz</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Alice Y</name>
      </author>
      <author>
        <name>Allison, Matthew</name>
        <uri>https://orcid.org/0000-0003-0777-8272</uri>
      </author>
      <author>
        <name>Puskarich, Michael</name>
      </author>
      <author>
        <name>Vilke, Gary M</name>
      </author>
      <author>
        <name>Taub, Pam</name>
        <uri>https://orcid.org/0000-0002-0684-0655</uri>
      </author>
      <author>
        <name>Criqui, Michael H</name>
        <uri>https://orcid.org/0000-0003-0425-9661</uri>
      </author>
      <author>
        <name>Wardi, Gabriel</name>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Castillo, Edward M</name>
      </author>
      <author>
        <name>Brennan, Jesse</name>
      </author>
      <author>
        <name>Coyne, Christopher</name>
      </author>
    </item>
    <item>
      <title>Ubiquitin-driven G protein-coupled receptor inflammatory signaling at the endosome</title>
      <link>https://escholarship.org/uc/item/4wx8t38p</link>
      <description>G protein-coupled receptors (GPCRs) are ubiquitously expressed cell surface receptors that mediate numerous physiological responses and are highly druggable. Upon activation, GPCRs rapidly couple to heterotrimeric G proteins and are then phosphorylated and internalized from the cell surface. Recent studies indicate that GPCRs not only localize at the plasma membrane but also exist in intracellular compartments where they are competent to signal. Intracellular signaling by GPCRs is best described to occur at endosomes. Several studies have elegantly documented endosomal GPCR-G protein and GPCR-β-arrestin signaling. Besides phosphorylation, GPCRs are also posttranslationally modified with ubiquitin. GPCR ubiquitination has been studied mainly in the context of receptor endosomal-lysosomal trafficking. However, new studies indicate that ubiquitination of endogenous GPCRs expressed in endothelial cells initiates the assembly of an intracellular p38 mitogen-activated kinase signaling...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wx8t38p</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cheng, Norton</name>
        <uri>https://orcid.org/0000-0002-0591-3963</uri>
      </author>
      <author>
        <name>Pimentel, Julio M</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
    </item>
    <item>
      <title>Scaling back DEI programmes and the loss of scientific talent</title>
      <link>https://escholarship.org/uc/item/0xj781vn</link>
      <description>Programmes that support diversity, equity and inclusion (DEI) in science are under attack in the USA. Data indicate that diversity in the scientific workforce increases creativity and success in tackling challenging problems. Loss of promising talent supported by these programmes will substantially weaken our research capacity, limit innovation and substantially reduce discoveries important for driving scientific advancements.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0xj781vn</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bhalla, Needhi</name>
        <uri>https://orcid.org/0000-0002-6859-0073</uri>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Munson, Mary</name>
      </author>
    </item>
    <item>
      <title>Oncogenic H-RAS induces metformin resistance in head and neck cancer by promoting glycolytic metabolism</title>
      <link>https://escholarship.org/uc/item/73s0b51w</link>
      <description>Metformin administration has recently emerged as a candidate strategy for the prevention of head and neck squamous cell carcinoma (HNSCC). However, the intricate relationship between genetic alterations in HNSCC and metformin sensitivity is still poorly understood, which prevents the stratification of patients, harboring oral premalignant lesions that may benefit from the chemopreventive activity of metformin. In this study, we investigate the impact of prevalent mutations in HNSCC on response to metformin. Notably, we found that the expression of oncogenic HRAS mutants confers resistance to metformin in isogenic HNSCC cell systems, and that HNSCC cells harboring endogenous HRAS mutations display limited sensitivity to metformin. Remarkably, we found that metformin fails to reduce activation of the mTOR pathway in HRAS oncogene-expressing HNSCC cells in vitro and in vivo, correlating with reduced tumor suppressive activity. Mechanistically, we found that this process depends on...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/73s0b51w</guid>
      <pubDate>Mon, 3 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Xingyu</name>
      </author>
      <author>
        <name>Adame-Garcia, Sendi Rafael</name>
      </author>
      <author>
        <name>Koshizuka, Keiichi</name>
      </author>
      <author>
        <name>Vo, Pham Thuy Tien</name>
      </author>
      <author>
        <name>Hoang, Thomas S</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Izumi, Hiroki</name>
      </author>
      <author>
        <name>Goto, Yusuke</name>
      </author>
      <author>
        <name>Allevato, Michael M</name>
      </author>
      <author>
        <name>Wood, Kris C</name>
      </author>
      <author>
        <name>Lippman, Scott M</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
    </item>
    <item>
      <title>Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness</title>
      <link>https://escholarship.org/uc/item/9gz4q08t</link>
      <description>Contact with dense collagen I (Col1) can induce collective invasion of triple negative breast cancer (TNBC) cells and transcriptional signatures linked to poor patient prognosis. However, this response is heterogeneous and not well understood. Using phenotype-guided sequencing analysis of invasive vs. noninvasive subpopulations, we show that these two phenotypes represent opposite sides of the iron response protein 1 (IRP1)-mediated response to cytoplasmic labile iron pool (cLIP) levels. Invasive cells upregulate iron uptake and utilization machinery characteristic of a low cLIP response, which includes contractility regulating genes that drive migration. Non-invasive cells upregulate iron sequestration machinery characteristic of a high cLIP response, which is accompanied by upregulation of actin sequestration genes. These divergent IRP1 responses result from Col1-induced transient expression of heme oxygenase I (HO-1), which cleaves heme and releases iron. These findings lend...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9gz4q08t</guid>
      <pubDate>Fri, 24 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Leineweber, William D</name>
      </author>
      <author>
        <name>Rowell, Maya Z</name>
      </author>
      <author>
        <name>Ranamukhaarachchi, Sural K</name>
      </author>
      <author>
        <name>Walker, Alyssa</name>
      </author>
      <author>
        <name>Li, Yajuan</name>
      </author>
      <author>
        <name>Villazon, Jorge</name>
      </author>
      <author>
        <name>Mestre-Farrera, Aida</name>
      </author>
      <author>
        <name>Hu, Zhimin</name>
      </author>
      <author>
        <name>Yang, Jing</name>
      </author>
      <author>
        <name>Shi, Lingyan</name>
      </author>
      <author>
        <name>Fraley, Stephanie I</name>
      </author>
    </item>
    <item>
      <title>Update on Epithelial-Mesenchymal Plasticity in Cancer Progression</title>
      <link>https://escholarship.org/uc/item/455403xb</link>
      <description>Epithelial-mesenchymal transition (EMT) is a cellular process by which epithelial cells lose their characteristics and acquire mesenchymal traits to promote cell movement. This program is aberrantly activated in human cancers and endows tumor cells with increased abilities in tumor initiation, cell migration, invasion, metastasis, and therapy resistance. The EMT program in tumors is rarely binary and often leads to a series of gradual or intermediate epithelial-mesenchymal states. Functionally, epithelial-mesenchymal plasticity (EMP) improves the fitness of cancer cells during tumor progression and in response to therapies. Here, we discuss the most recent advances in our understanding of the diverse roles of EMP in tumor initiation, progression, metastasis, and therapy resistance and address major clinical challenges due to EMP-driven phenotypic heterogeneity in cancer. Uncovering novel molecular markers and key regulators of EMP in cancer will aid the development of new therapeutic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/455403xb</guid>
      <pubDate>Fri, 24 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Fontana, Rosa</name>
      </author>
      <author>
        <name>Mestre-Farrera, Aida</name>
      </author>
      <author>
        <name>Yang, Jing</name>
      </author>
    </item>
    <item>
      <title>Sensitive fluorescent biosensor reveals differential subcellular regulation of PKC</title>
      <link>https://escholarship.org/uc/item/0f72p8rw</link>
      <description>The protein kinase C (PKC) family of serine and threonine kinases, consisting of three distinctly regulated subfamilies, has been established as critical for various cellular functions. However, how PKC enzymes are regulated at different subcellular locations, particularly at emerging signaling hubs, is unclear. Here we present a sensitive excitation ratiometric C kinase activity reporter (ExRai-CKAR2) that enables the detection of minute changes (equivalent to 0.2% of maximum stimulation) in subcellular PKC activity. Using ExRai-CKAR2 with an enhanced diacylglycerol (DAG) biosensor, we uncover that G-protein-coupled receptor stimulation triggers sustained PKC activity at the endoplasmic reticulum and lysosomes, differentially mediated by Ca2+-sensitive conventional PKC and DAG-sensitive novel PKC, respectively. The high sensitivity of ExRai-CKAR2, targeted to either the cytosol or partitioning defective complexes, further enabled us to detect previously inaccessible endogenous...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f72p8rw</guid>
      <pubDate>Tue, 21 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Su, Qi</name>
      </author>
      <author>
        <name>Zhang, Jing</name>
      </author>
      <author>
        <name>Lin, Wei</name>
      </author>
      <author>
        <name>Zhang, Jin-Fan</name>
      </author>
      <author>
        <name>Newton, Alexandra C</name>
      </author>
      <author>
        <name>Mehta, Sohum</name>
        <uri>https://orcid.org/0000-0003-4764-8579</uri>
      </author>
      <author>
        <name>Yang, Jing</name>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
    </item>
    <item>
      <title>Protocol to separate small and large extracellular vesicles from mouse and human cardiac tissues</title>
      <link>https://escholarship.org/uc/item/8737x5zf</link>
      <description>Extracellular vesicles (EVs) are secreted by cells under various conditions and can contribute to the disease progression in tissues. Here, we present a protocol to separate small and large EVs from mouse hearts and cardiac tissues collected from patients. We describe steps for utilizing enzymatic digestion for release of EVs from interstitial space followed by differential centrifugation and immunoaffinity purification. The isolated EVs can be used for various experiments to gain insight into their in&amp;nbsp;vivo functions. For complete details on the use and execution of this protocol, please refer to Liang et&amp;nbsp;al. (2023).&lt;sup&gt;1&lt;/sup&gt;.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8737x5zf</guid>
      <pubDate>Tue, 30 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Liang, Wenjing</name>
      </author>
      <author>
        <name>Najor, Rita H</name>
      </author>
      <author>
        <name>Gustafsson, Åsa B</name>
      </author>
    </item>
    <item>
      <title>Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing</title>
      <link>https://escholarship.org/uc/item/1676z83d</link>
      <description>Mitochondria are multifunctional organelles that are important for many different cellular processes, including energy production and biosynthesis of fatty acids, haem and iron–sulfur clusters. Mitochondrial dysfunction leads to a disruption in these processes, the generation of excessive reactive oxygen species, and the activation of inflammatory and cell death pathways. The consequences of mitochondrial dysfunction are particularly harmful in energy-demanding organs such as the heart. Loss of terminally differentiated cardiomyocytes leads to cardiac remodelling and a reduced ability to sustain contraction. Therefore, cardiomyocytes rely on multilayered mitochondrial quality control mechanisms to maintain a healthy population of mitochondria. Mitochondrial chaperones protect against protein misfolding and aggregation, and resident proteases eliminate damaged proteins through proteolysis. Irreparably damaged mitochondria can also be degraded through mitochondrial autophagy (mitophagy)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1676z83d</guid>
      <pubDate>Tue, 30 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ravindran, Rishith</name>
      </author>
      <author>
        <name>Gustafsson, Åsa B</name>
      </author>
    </item>
    <item>
      <title>Protocol for differentiating murine 3T3-L1 and SVF-derived preadipocytes and isolating crude mitochondrial fractions</title>
      <link>https://escholarship.org/uc/item/45s4v8b8</link>
      <description>Here, we present a protocol for differentiating 3T3-L1 preadipocytes and stromal vascular fraction (SVF)-derived preadipocytes from mice into mature adipocytes, followed by the isolation of crude mitochondrial fractions. This cost-effective and reproducible protocol is optimized for small-plate formats, compatible with standard reagents, and suitable for metabolic studies such as insulin resistance and mitochondrial function.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/45s4v8b8</guid>
      <pubDate>Thu, 11 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wisessaowapak, Churaibhon</name>
      </author>
      <author>
        <name>Lee, Jeongmin</name>
      </author>
      <author>
        <name>Kim, Hyeonhui</name>
      </author>
      <author>
        <name>Son, Seunghwan</name>
      </author>
      <author>
        <name>Feng, Xue</name>
      </author>
      <author>
        <name>Chang, Lina</name>
      </author>
      <author>
        <name>Hoang, Annie</name>
      </author>
      <author>
        <name>Chen, Hetty</name>
      </author>
      <author>
        <name>Bedsted, Sarah</name>
      </author>
      <author>
        <name>Saltiel, Alan R</name>
        <uri>https://orcid.org/0000-0002-9726-9828</uri>
      </author>
    </item>
    <item>
      <title>An alternative pocket for binding the N‐degrons by the UBR1 and UBR2 ubiquitin E3 ligases</title>
      <link>https://escholarship.org/uc/item/3f8020kv</link>
      <description>The UBR family of ubiquitin ligases binds to N-termini of their targets (known as N-degron) to induce their ubiquitination and degradation via a conserved domain known as UBR-box. UBR1 and UBR2 share the highest sequence homology among the family, and substantial structural studies were previously performed for substrate binding by the UBR-boxes of UBR1 and UBR2. Here, we describe a new pocket in the UBR-boxes of UBR1 and UBR2 for binding the second residues of N-degrons through determining five co-crystal structures of the UBR-boxes with various N-degron peptides. Together with binding affinities measured by fluorescence polarization, we show that the two highly homologous UBR-boxes can interact with the second residue of an N-degron differently. In addition, the UBR-boxes undergo different conformational changes when binding N-degrons. Furthermore, we demonstrate that the sidechain of the third amino acid of an N-degron has no contribution to binding the UBR-boxes. These findings...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3f8020kv</guid>
      <pubDate>Tue, 9 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Huang, Shih‐Ting</name>
      </author>
      <author>
        <name>Chen, Dai‐Hua</name>
      </author>
      <author>
        <name>Ren, Tianchen</name>
      </author>
      <author>
        <name>Thomas, Nicole</name>
      </author>
      <author>
        <name>Wu, Jian</name>
        <uri>https://orcid.org/0000-0002-8031-9462</uri>
      </author>
      <author>
        <name>Sankaran, Banumathi</name>
      </author>
      <author>
        <name>Jones, Renee</name>
      </author>
      <author>
        <name>Taylor, Susan</name>
      </author>
      <author>
        <name>Chen, Yuan</name>
      </author>
    </item>
    <item>
      <title>The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy</title>
      <link>https://escholarship.org/uc/item/79w4r3qf</link>
      <description>Surgical ablation or broad radiation of tumor-draining lymph nodes can eliminate the primary tumor response to immunotherapy, highlighting the crucial role of these nodes in mediating the primary tumor response. Here, we show that immunoradiotherapy efficacy is dependent on treatment sequence and migration of modulated dendritic cells from tumor to sentinel lymph nodes. Using a tamoxifen-inducible reporter paired with CITE-sequencing in a murine model of oral cancer, we comprehensively characterize tumor immune cellular migration through lymphatic channels to sentinel lymph nodes at single-cell resolution, revealing a unique immunologic niche defined by distinct cellular phenotypic and transcriptional profiles. Through a structured approach of sequential immunomodulatory radiotherapy and checkpoint inhibition, we show that sequenced, lymphatic-sparing, tumor-directed radiotherapy followed by PD-1 inhibition achieves complete and durable tumor responses. Mechanistically, this treatment...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/79w4r3qf</guid>
      <pubDate>Fri, 1 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Saddawi-Konefka, Robert</name>
      </author>
      <author>
        <name>Msari, Riyam Al</name>
      </author>
      <author>
        <name>Tang, Shiqi</name>
      </author>
      <author>
        <name>Philips, Chad</name>
      </author>
      <author>
        <name>Sadat, Sayed</name>
      </author>
      <author>
        <name>Clubb, Lauren M</name>
      </author>
      <author>
        <name>Luna, Sarah</name>
      </author>
      <author>
        <name>Fassardi, Santiago</name>
      </author>
      <author>
        <name>Jones, Riley</name>
      </author>
      <author>
        <name>Pietryga, Ida Franiak</name>
      </author>
      <author>
        <name>Faraji, Farhoud</name>
      </author>
      <author>
        <name>Schokrpur, Shiruyeh</name>
      </author>
      <author>
        <name>Yung, Bryan S</name>
      </author>
      <author>
        <name>Allevato, Michael M</name>
      </author>
      <author>
        <name>Decker, Kelsey E</name>
      </author>
      <author>
        <name>Nasamran, Chanond A</name>
      </author>
      <author>
        <name>Chilin-Fuentes, Daisy</name>
      </author>
      <author>
        <name>Rosenthal, Sara Brin</name>
      </author>
      <author>
        <name>Jensen, Shawn M</name>
      </author>
      <author>
        <name>Fox, Bernard A</name>
      </author>
      <author>
        <name>Bell, R Bryan</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Sharabi, Andrew</name>
      </author>
      <author>
        <name>Califano, Joseph A</name>
      </author>
    </item>
    <item>
      <title>Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium</title>
      <link>https://escholarship.org/uc/item/0kv6f646</link>
      <description>OBJECTIVE: Oxylipins are bioactive lipids derived from polyunsaturated fatty acids (PUFAs) that modulate inflammation and may remain overexpressed in refractory synovitis. In plasma, they could also be biomarkers of synovial pathology. The aim of this study is to determine if synovial oxylipins in inflamed joints correlate with plasma oxylipins and with synovial histologic patterns.
METHODS: Patients with established rheumatoid or psoriatic arthritis with active disease despite treatment were recruited, and paired synovial tissue (ST) and plasma were collected. Oxylipins were determined by liquid chromatography with tandem mass spectrometry and were classified into groups according to their PUFA precursor and enzyme. The expression of CD20, CD68, CD3, and CD138 was obtained to describe synovial histology. Cell-specific expression of oxylipin-related genes was identified by examining available synovial single-cell RNA sequencing data.
RESULTS: We included a total of 32 ST and 26...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kv6f646</guid>
      <pubDate>Thu, 3 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Murillo‐Saich, Jessica D</name>
      </author>
      <author>
        <name>Coras, Roxana</name>
      </author>
      <author>
        <name>Ramirez, Julio</name>
      </author>
      <author>
        <name>Quesada‐Masachs, Estefania</name>
      </author>
      <author>
        <name>Sala‐Climent, Marta</name>
      </author>
      <author>
        <name>Eschelbach, Katharina</name>
      </author>
      <author>
        <name>Mahony, Christopher B</name>
      </author>
      <author>
        <name>Celis, Raquel</name>
      </author>
      <author>
        <name>Armando, Aaron</name>
      </author>
      <author>
        <name>Quehenberger, Oswald</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>Croft, Adam P</name>
      </author>
      <author>
        <name>Kavanaugh, Arthur</name>
      </author>
      <author>
        <name>Chang, Eric</name>
      </author>
      <author>
        <name>Cañete, Juan D</name>
      </author>
      <author>
        <name>Singh, Abha</name>
      </author>
      <author>
        <name>Guma, Monica</name>
        <uri>https://orcid.org/0000-0003-1951-9411</uri>
      </author>
    </item>
    <item>
      <title>A comprehensive classification system for lipids</title>
      <link>https://escholarship.org/uc/item/8p378979</link>
      <description>Abstract: 
Lipids are produced, transported, and recognized by the concerted actions of numerous enzymes, binding proteins, and receptors. A comprehensive analysis of lipid molecules, “lipidomics,” in the context of genomics and proteomics is crucial to understanding cellular physiology and pathology; consequently, lipid biology has become a major research target of the postgenomic revolution and systems biology. To facilitate international communication about lipids, a comprehensive classification of lipids with a common platform that is compatible with informatics requirements has been developed to deal with the massive amounts of data that will be generated by our lipid community. As an initial step in this development, we divide lipids into eight categories (fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides) containing distinct classes and subclasses of molecules, devise a common manner of representing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8p378979</guid>
      <pubDate>Fri, 27 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Fahy, Eoin</name>
      </author>
      <author>
        <name>Subramaniam, Shankar</name>
      </author>
      <author>
        <name>Brown, H Alex</name>
      </author>
      <author>
        <name>Glass, Christopher K</name>
      </author>
      <author>
        <name>Merrill, Alfred H</name>
      </author>
      <author>
        <name>Murphy, Robert C</name>
      </author>
      <author>
        <name>Raetz, Christian RH</name>
      </author>
      <author>
        <name>Russell, David W</name>
      </author>
      <author>
        <name>Seyama, Yousuke</name>
      </author>
      <author>
        <name>Shaw, Walter</name>
      </author>
      <author>
        <name>Shimizu, Takao</name>
      </author>
      <author>
        <name>Spener, Friedrich</name>
      </author>
      <author>
        <name>van Meer, Gerrit</name>
      </author>
      <author>
        <name>VanNieuwenhze, Michael S</name>
      </author>
      <author>
        <name>White, Stephen H</name>
        <uri>https://orcid.org/0000-0001-8540-7907</uri>
      </author>
      <author>
        <name>Witztum, Joseph L</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
    </item>
    <item>
      <title>The LIPID maps approach to lipidomics</title>
      <link>https://escholarship.org/uc/item/7n99j30z</link>
      <description>A five-year, large-scale collaborative “Glue Grant” (funds providing the “glue” to bring investigators together, allowing them to work interactively) was funded by the National Institute of General Medical Sciences (NIGMS) in August 2003 to develop a LIPID Metabolites and Pathways Strategy, known as LIPID MAPS. The goals of the LIPID MAPS Consortium are: (1) to separate and detect all of the lipids in a specific cell and to discover and characterize novel lipids that may be present, (2) to quantitate each of the lipid metabolites present and determine the changes in their levels and locations during cellular function, and (3) to define biosynthetic pathways for each lipid and develop lipid maps that define interaction networks.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7n99j30z</guid>
      <pubDate>Wed, 25 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dennis, EA</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
      <author>
        <name>Alex Brown, H</name>
      </author>
      <author>
        <name>Deems, RA</name>
      </author>
      <author>
        <name>Glass, CK</name>
      </author>
      <author>
        <name>Merrill, AH</name>
      </author>
      <author>
        <name>Murphy, RC</name>
      </author>
      <author>
        <name>Raetz, CRH</name>
      </author>
      <author>
        <name>Shaw, W</name>
      </author>
      <author>
        <name>Subramaniam, S</name>
      </author>
      <author>
        <name>Russell, DW</name>
      </author>
      <author>
        <name>Van Nieuwenhze, MS</name>
      </author>
      <author>
        <name>White, SH</name>
        <uri>https://orcid.org/0000-0001-8540-7907</uri>
      </author>
      <author>
        <name>Witztum, JL</name>
      </author>
      <author>
        <name>Wooley, J</name>
      </author>
    </item>
    <item>
      <title>Elucidating VEGF Biology: A Journey of Discovery and Clinical Translation</title>
      <link>https://escholarship.org/uc/item/7g92z9pj</link>
      <description>Elucidating VEGF Biology: A Journey of Discovery and Clinical Translation</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7g92z9pj</guid>
      <pubDate>Thu, 19 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mori, Tommaso</name>
      </author>
      <author>
        <name>Kumar, Naresh</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
    </item>
    <item>
      <title>ARRDC3 tyrosine phosphorylation functions as a switch to control c-Src versus WWP2 interactions and distinct scaffolding functions</title>
      <link>https://escholarship.org/uc/item/2016221k</link>
      <description>Mammalian α-arrestins are members of the same arrestin family as the ubiquitously expressed and extensively studied β-arrestins. Arrestins share common structural elements, including the conserved N- and C-arrestin-fold domains, polar core, finger loop, and C-terminal tail, all of which mediate protein-protein interactions. In β-arrestins, these domains enable the control of G protein-coupled receptor (GPCR) signaling and scaffolding interactions with various signaling proteins including c-Src. By contrast, the repertoire of α-arrestin scaffolding partners and regulatory mechanisms that control their interactions are not well-understood. α-arrestins differ considerably from β-arrestins in the C-terminal region; β-arrestins contain clathrin adaptor β-adaptin-binding sites, whereas α-arrestins harbor PPxY motifs, demonstrated to interact with WW domains of E3 ubiquitin ligases such as WWP2. Here we report the identification of a novel phosphorylation site, tyrosine (Y) 394, embedded...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2016221k</guid>
      <pubDate>Tue, 17 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Caplan, Mika</name>
      </author>
      <author>
        <name>Bardeleben, Carolyne</name>
      </author>
      <author>
        <name>Dhawan, Kanika</name>
        <uri>https://orcid.org/0000-0002-6267-0312</uri>
      </author>
      <author>
        <name>Plawat, Rhea</name>
      </author>
      <author>
        <name>Kufareva, Irina</name>
        <uri>https://orcid.org/0000-0001-9083-7039</uri>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
    </item>
    <item>
      <title>USP34 regulates endothelial PAR1 mRNA transcript expression and cellular signaling</title>
      <link>https://escholarship.org/uc/item/1tw3v0t9</link>
      <description>Signaling by G protein-coupled receptors (GPCRs) is regulated by temporally distinct processes including receptor desensitization, internalization, and lysosomal sorting, and are tightly controlled by posttranslational modifications. While the role of phosphorylation in regulating GPCR signaling is well studied and established, the mechanisms by which other posttranslational modifications, such as ubiquitination, regulate GPCR signaling are not clearly defined. We hypothesize that GPCR ubiquitination and deubiquitination is critical for proper signaling and cellular responses. In the present study, we show that the deubiquitinase ubiquitin-specific protease-34 (USP34) regulates thrombin-stimulated protease-activated receptor-1 (PAR1)-induced p38 autophosphorylation and activation. The PAR1-stimulated p38 signaling pathway is driven by ubiquitination. Interestingly, small interfering RNA-induced knockdown of USP34 expression markedly increased PAR1 cell surface abundance and protein...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tw3v0t9</guid>
      <pubDate>Tue, 17 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cheng, Norton</name>
        <uri>https://orcid.org/0000-0002-0591-3963</uri>
      </author>
      <author>
        <name>Ramirez, Monica Gonzalez</name>
      </author>
      <author>
        <name>Edwards, Chloe</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
    </item>
    <item>
      <title>Bright and photostable yellow fluorescent proteins for extended imaging</title>
      <link>https://escholarship.org/uc/item/4282361x</link>
      <description>Fluorescent proteins are indispensable molecular tools for visualizing biological structures and processes, but their limited photostability restricts the duration of dynamic imaging experiments. Yellow fluorescent proteins (YFPs), in particular, photobleach rapidly. Here, we introduce mGold2s and mGold2t, YFPs with up to 25-fold greater photostability than mVenus and mCitrine, two commonly used YFPs, while maintaining comparable brightness. These variants were identified using a high-throughput pooled single-cell platform, simultaneously screening for high brightness and photostability. Compared with our previous benchmark, mGold, the mGold2 variants display a ~4-fold increase in photostability without sacrificing brightness. mGold2s and mGold2t extend imaging durations across diverse modalities, including widefield, total internal reflection fluorescence (TIRF), super-resolution, single-molecule, and laser-scanning confocal microscopy. When incorporated into fluorescence resonance...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4282361x</guid>
      <pubDate>Thu, 24 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Jihwan</name>
      </author>
      <author>
        <name>Lai, Shujuan</name>
      </author>
      <author>
        <name>Yang, Shuyuan</name>
      </author>
      <author>
        <name>Zhao, Shiqun</name>
      </author>
      <author>
        <name>Blanco, Francisco A</name>
      </author>
      <author>
        <name>Lyons, Anne C</name>
      </author>
      <author>
        <name>Merino-Urteaga, Raquel</name>
      </author>
      <author>
        <name>Ahrens, John F</name>
      </author>
      <author>
        <name>Nguyen, Nathan A</name>
      </author>
      <author>
        <name>Liu, Haixin</name>
      </author>
      <author>
        <name>Liu, Zhuohe</name>
      </author>
      <author>
        <name>Lambert, Gerard G</name>
      </author>
      <author>
        <name>Shaner, Nathan C</name>
        <uri>https://orcid.org/0000-0002-0148-0769</uri>
      </author>
      <author>
        <name>Chen, Liangyi</name>
      </author>
      <author>
        <name>Tolias, Kimberley F</name>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
      <author>
        <name>Ha, Taekjip</name>
      </author>
      <author>
        <name>St-Pierre, François</name>
      </author>
    </item>
    <item>
      <title>Leveraging Optical Anisotropy of the Morpho Butterfly Wing for Quantitative, Stain‐Free, and Contact‐Free Assessment of Biological Tissue Microstructures</title>
      <link>https://escholarship.org/uc/item/9t61d6mm</link>
      <description>Changes in the density and organization of fibrous biological tissues often accompany the progression of serious diseases ranging from fibrosis to neurodegenerative diseases, heart disease and cancer. However, challenges in cost, complexity, or precision faced by existing imaging methodologies and materials pose barriers to elucidating the role of tissue microstructure in disease. Here, we leverage the intrinsic optical anisotropy of the Morpho butterfly wing and introduce Morpho-Enhanced Polarized Light Microscopy (MorE-PoL), a stain- and contact-free imaging platform that enhances and quantifies the birefringent material properties of fibrous biological tissues. We develop a mathematical model, based on Jones calculus, which describes fibrous tissue density and organization. As a representative example, we analyzed collagen-dense and collagen-sparse human breast cancer tissue sections and leverage our technique to assess the microstructural properties of distinct regions of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9t61d6mm</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Kirya, Paula</name>
      </author>
      <author>
        <name>Mestre‐Farrera, Aida</name>
      </author>
      <author>
        <name>Yang, Jing</name>
      </author>
      <author>
        <name>Poulikakos, Lisa V</name>
      </author>
    </item>
    <item>
      <title>Effects of sotagliflozin on kidney and cardiac outcome in a hypertensive model of subtotal nephrectomy in male mice</title>
      <link>https://escholarship.org/uc/item/1853h63t</link>
      <description>Dual inhibition of sodium glucose cotransporters 1 and 2 (SGLT1/SGLT2) by sotagliflozin protects the kidney and heart in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). To gain mechanistic insights, the current study aimed to establish a murine model of hypertensive CKD that shows cardio-renal protection by sotagliflozin. Since protection by SGLT2 inhibitors can be diabetes-independent, a nondiabetic murine model of subtotal nephrectomy with angiotensin II infusion-facilitated hypertension was followed for 7 weeks. The model showed 40% lower GFR, doubling in plasma FGF23, 50 mmHg higher systolic blood pressure (SBP), 100-fold increased albuminuria, and robust signs of kidney injury, inflammation, and fibrosis versus sham controls, associated with a 30% larger left cardiac ventricle and wall thickness and upregulation of markers of cardiac overload and fibrosis. Sotagliflozin, initiated 1 week after the last surgery, showed target-engagement evidenced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1853h63t</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Goodluck, Helen</name>
      </author>
      <author>
        <name>Zemljic‐Harpf, Alice</name>
      </author>
      <author>
        <name>Galdino, Ony Araujo</name>
      </author>
      <author>
        <name>Kanoo, Sadhana</name>
      </author>
      <author>
        <name>Lopez, Natalia</name>
      </author>
      <author>
        <name>Kim, Young Chul</name>
        <uri>https://orcid.org/0000-0002-6782-2186</uri>
      </author>
      <author>
        <name>Vallon, Volker</name>
        <uri>https://orcid.org/0000-0002-9211-2063</uri>
      </author>
    </item>
    <item>
      <title>Effects of sotagliflozin on kidney and cardiac outcome in a hypertensive model of subtotal nephrectomy in male mice</title>
      <link>https://escholarship.org/uc/item/9mh5105w</link>
      <description>Dual inhibition of sodium glucose cotransporters 1 and 2 (SGLT1/SGLT2) by sotagliflozin protects the kidney and heart in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). To gain mechanistic insights, the current study aimed to establish a murine model of hypertensive CKD that shows cardio-renal protection by sotagliflozin. Since protection by SGLT2 inhibitors can be diabetes-independent, a nondiabetic murine model of subtotal nephrectomy with angiotensin II infusion-facilitated hypertension was followed for 7 weeks. The model showed 40% lower GFR, doubling in plasma FGF23, 50 mmHg higher systolic blood pressure (SBP), 100-fold increased albuminuria, and robust signs of kidney injury, inflammation, and fibrosis versus sham controls, associated with a 30% larger left cardiac ventricle and wall thickness and upregulation of markers of cardiac overload and fibrosis. Sotagliflozin, initiated 1 week after the last surgery, showed target-engagement evidenced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9mh5105w</guid>
      <pubDate>Mon, 7 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Goodluck, Helen</name>
      </author>
      <author>
        <name>Zemljic‐Harpf, Alice</name>
      </author>
      <author>
        <name>Galdino, Ony Araujo</name>
      </author>
      <author>
        <name>Kanoo, Sadhana</name>
      </author>
      <author>
        <name>Lopez, Natalia</name>
      </author>
      <author>
        <name>Kim, Young Chul</name>
        <uri>https://orcid.org/0000-0002-6782-2186</uri>
      </author>
      <author>
        <name>Vallon, Volker</name>
        <uri>https://orcid.org/0000-0002-9211-2063</uri>
      </author>
    </item>
    <item>
      <title>CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy</title>
      <link>https://escholarship.org/uc/item/4jv6b7cz</link>
      <description>Monocytes infiltrating tumors acquire various states that distinctly impact cancer treatment. Here, we show that resistance of tumors to radiotherapy (RT) is controlled by the accumulation of monocyte-derived dendritic cells (moDCs). These moDCs are characterized by the expression of CD301b and have a superior capacity to generate regulatory T cells (Tregs). Accordingly, moDC depletion limits Treg generation and improves the therapeutic outcome of RT. Mechanistically, we demonstrate that granulocyte-macrophage colony-stimulating factor (GM-CSF) derived from radioresistant tumor cells following RT is necessary for the accumulation of moDCs. Our results unravel the immunosuppressive function of moDCs and identify GM-CSF as an immunotherapeutic target during RT.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4jv6b7cz</guid>
      <pubDate>Fri, 4 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Tadepalli, Sirimuvva</name>
      </author>
      <author>
        <name>Clements, Derek R</name>
      </author>
      <author>
        <name>Raquer-McKay, Hayley M</name>
      </author>
      <author>
        <name>Lüdtke, Anja</name>
      </author>
      <author>
        <name>Saravanan, Sanjana</name>
      </author>
      <author>
        <name>Seong, David</name>
      </author>
      <author>
        <name>Vitek, Lorraine</name>
      </author>
      <author>
        <name>Richards, Christopher M</name>
      </author>
      <author>
        <name>Carette, Jan E</name>
      </author>
      <author>
        <name>Mack, Matthias</name>
      </author>
      <author>
        <name>Gottfried-Blackmore, Andres</name>
      </author>
      <author>
        <name>Graves, Edward E</name>
      </author>
      <author>
        <name>Idoyaga, Juliana</name>
        <uri>https://orcid.org/0000-0002-4430-8862</uri>
      </author>
    </item>
    <item>
      <title>Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress</title>
      <link>https://escholarship.org/uc/item/7371p5sf</link>
      <description>Endothelial cells throughout the body sense blood flow, eliciting transcriptional and phenotypic responses. The brain endothelium, known as the blood-brain barrier (BBB), possesses unique barrier and transport properties, which are in part regulated by blood flow. We utilized RNA sequencing to analyze the transcriptome of primary cultured rat brain microvascular endothelial cells (BMECs), as well as three human induced pluripotent stem cell-derived models. We compared the transcriptional responses of these cells to either low (0.5 dyne/cm&lt;sup&gt;2&lt;/sup&gt;) or high (12 dyne/cm&lt;sup&gt;2&lt;/sup&gt;) shear stresses, and subsequent analyses identified genes and pathways that were influenced by shear including key BBB-associated genes (&lt;i&gt;SLC2A1&lt;/i&gt;, &lt;i&gt;LSR&lt;/i&gt;, &lt;i&gt;PLVAP&lt;/i&gt;) and canonical endothelial shear-stress-response transcription factors (&lt;i&gt;KLF2&lt;/i&gt;, &lt;i&gt;KLF4&lt;/i&gt;). In addition, our analysis suggests that shear alone is insufficient to rescue the de-differentiation caused by in vitro primary...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7371p5sf</guid>
      <pubDate>Wed, 2 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Foreman, Koji L</name>
      </author>
      <author>
        <name>Gastfriend, Benjamin D</name>
        <uri>https://orcid.org/0000-0002-4677-1455</uri>
      </author>
      <author>
        <name>Katt, Moriah E</name>
      </author>
      <author>
        <name>Palecek, Sean P</name>
      </author>
      <author>
        <name>Shusta, Eric V</name>
      </author>
    </item>
    <item>
      <title>Lipid storage disease in 4 sibling superb birds-of-paradise (Lophorina superba)</title>
      <link>https://escholarship.org/uc/item/6tp1k04j</link>
      <description>Pedigree analysis, clinical, gross, microscopic, ultrastructural, and lipidomic findings in 4 female superb bird-of-paradise (SBOP, &lt;i&gt;Lophorina superba&lt;/i&gt;) siblings led to the diagnosis of a primary inherited glycerolipid storage disease. These birds were the offspring of a related breeding pair (inbreeding coefficient = 0.1797) and are the only known SBOPs to display this constellation of lesions. The birds ranged from 0.75 to 4.3 years of age at the time of death. Two birds were euthanized and 1 died naturally due to the disease, and 1 died of head trauma with no prior clinical signs. Macroscopic findings included hepatomegaly and pallor (4/4), cardiac and renal pallor (2/4), and coelomic effusion (1/4). Microscopic examination found marked tissue distortion due to cytoplasmic lipid vacuoles in hepatocytes (4/4), cardiomyocytes (4/4), renal tubular epithelial cells (4/4), parathyroid gland principal cells (2/2), exocrine pancreatic cells (3/3), and the glandular cells of the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6tp1k04j</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>McKenzie, Christina M</name>
      </author>
      <author>
        <name>Marinkovich, Matt</name>
      </author>
      <author>
        <name>Armién, Aníbal G</name>
      </author>
      <author>
        <name>St. Leger, Judy</name>
      </author>
      <author>
        <name>Armando, Aaron M</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
      <author>
        <name>Quehenberger, Oswald</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>Righton, Alison</name>
      </author>
    </item>
    <item>
      <title>How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?</title>
      <link>https://escholarship.org/uc/item/5kr2x4ng</link>
      <description>What mechanisms can link the inhibition of sodium-glucose cotransporter 2 (SGLT2) in the early proximal tubule to kidney and heart protection in patients with and without type 2 diabetes? Due to physical and functional coupling of SGLT2 to other sodium and metabolite transporters in the early proximal tubule (including NHE3, URAT1), inhibitors of SGLT2 (SGLT2i) reduce reabsorption not only of glucose, inducing osmotic diuresis, but of other metabolites plus of a larger amount of sodium than expected based on SGLT2 inhibition alone, thereby reducing volume retention, hypertension and hyperuricemia. Metabolic adaptations to SGLT2i include a fasting-like response, with enhanced lipolysis and formation of ketone bodies that serve as additional fuel for kidneys and heart. Making use of the physiology of tubulo-glomerular communication, SGLT2i functionally lower glomerular capillary pressure and filtration rate, thereby reducing physical stress on the glomerular filtration barrier,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5kr2x4ng</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vallon, Volker</name>
        <uri>https://orcid.org/0000-0002-9211-2063</uri>
      </author>
    </item>
    <item>
      <title>Structural mechanisms of α7 nicotinic receptor allosteric modulation and activation</title>
      <link>https://escholarship.org/uc/item/8wd738qg</link>
      <description>The α7 nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel that plays an important role in cholinergic signaling throughout the nervous system. Its unique physiological characteristics and implications in neurological disorders and inflammation make it a promising but challenging therapeutic target. Positive allosteric modulators overcome limitations of traditional α7 agonists, but their potentiation mechanisms remain unclear. Here, we present high-resolution structures of α7-modulator complexes, revealing partially overlapping binding sites but varying conformational states. Structure-guided functional and computational tests suggest that differences in modulator activity arise from the stable rotation of a channel gating residue out of the pore. We extend the study using a time-resolved cryoelectron microscopy (cryo-EM) approach to reveal asymmetric state transitions for this homomeric channel and also find that a modulator with allosteric agonist activity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8wd738qg</guid>
      <pubDate>Sat, 8 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Burke, Sean M</name>
      </author>
      <author>
        <name>Avstrikova, Mariia</name>
      </author>
      <author>
        <name>Noviello, Colleen M</name>
      </author>
      <author>
        <name>Mukhtasimova, Nuriya</name>
      </author>
      <author>
        <name>Changeux, Jean-Pierre</name>
      </author>
      <author>
        <name>Thakur, Ganesh A</name>
      </author>
      <author>
        <name>Sine, Steven M</name>
      </author>
      <author>
        <name>Cecchini, Marco</name>
      </author>
      <author>
        <name>Hibbs, Ryan E</name>
      </author>
    </item>
    <item>
      <title>Multiscale modeling shows how 2’-deoxy-ATP rescues ventricular function in heart failure</title>
      <link>https://escholarship.org/uc/item/1th2s63v</link>
      <description>2'-deoxy-ATP (dATP) improves cardiac function by increasing the rate of crossbridge cycling and Ca[Formula: see text] transient decay. However, the mechanisms of these effects and how therapeutic responses to dATP are achieved when dATP is only a small fraction of the total ATP pool remain poorly understood. Here, we used a multiscale computational modeling approach to analyze the mechanisms by which dATP improves ventricular function. We integrated atomistic simulations of prepowerstroke myosin and actomyosin association, filament-scale Markov state modeling of sarcomere mechanics, cell-scale analysis of myocyte Ca[Formula: see text] dynamics and contraction, organ-scale modeling of biventricular mechanoenergetics, and systems level modeling of circulatory dynamics. Molecular and Brownian dynamics simulations showed that dATP increases the actomyosin association rate by 1.9 fold. Markov state models predicted that dATP increases the pool of myosin heads available for crossbridge...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1th2s63v</guid>
      <pubDate>Sat, 1 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Teitgen, Abigail E</name>
      </author>
      <author>
        <name>Hock, Marcus T</name>
      </author>
      <author>
        <name>McCabe, Kimberly J</name>
      </author>
      <author>
        <name>Childers, Matthew C</name>
      </author>
      <author>
        <name>Huber, Gary A</name>
      </author>
      <author>
        <name>Marzban, Bahador</name>
      </author>
      <author>
        <name>Beard, Daniel A</name>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
      <author>
        <name>Regnier, Michael</name>
      </author>
      <author>
        <name>McCulloch, Andrew D</name>
        <uri>https://orcid.org/0000-0002-1708-5675</uri>
      </author>
    </item>
    <item>
      <title>Next-Generation Genetically Encoded Fluorescent Biosensors Illuminate Cell Signaling and Metabolism</title>
      <link>https://escholarship.org/uc/item/7z81q013</link>
      <description>Genetically encoded fluorescent biosensors have revolutionized the study of cell signaling and metabolism, as they allow for live-cell measurements with high spatiotemporal resolution. This success has spurred the development of tailor-made biosensors that enable the study of dynamic phenomena on different timescales and length scales. In this review, we discuss different approaches to enhancing and developing new biosensors. We summarize the technologies used to gain structural insights into biosensor design and comment on useful screening technologies. Furthermore, we give an overview of different applications where biosensors have led to key advances over recent years. Finally, we give our perspective on where future work is bound to make a large impact.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7z81q013</guid>
      <pubDate>Mon, 17 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Frei, Michelle S</name>
      </author>
      <author>
        <name>Mehta, Sohum</name>
        <uri>https://orcid.org/0000-0003-4764-8579</uri>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
    </item>
    <item>
      <title>Spatial modeling algorithms for reactions and transport in biological cells</title>
      <link>https://escholarship.org/uc/item/7kg1k5bj</link>
      <description>Biological cells rely on precise spatiotemporal coordination of biochemical reactions to control their functions. Such cell signaling networks have been a common focus for mathematical models, but they remain challenging to simulate, particularly in realistic cell geometries. Here we present Spatial Modeling Algorithms for Reactions and Transport (SMART), a software package that takes in high-level user specifications about cell signaling networks and then assembles and solves the associated mathematical systems. SMART uses state-of-the-art finite element analysis, via the FEniCS Project software, to efficiently and accurately resolve cell signaling events over discretized cellular and subcellular geometries. We demonstrate its application to several different biological systems, including yes-associated protein (YAP)/PDZ-binding motif (TAZ) mechanotransduction, calcium signaling in neurons and cardiomyocytes, and ATP generation in mitochondria. Throughout, we utilize experimentally...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7kg1k5bj</guid>
      <pubDate>Mon, 17 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Francis, Emmet A</name>
      </author>
      <author>
        <name>Laughlin, Justin G</name>
      </author>
      <author>
        <name>Dokken, Jørgen S</name>
      </author>
      <author>
        <name>Finsberg, Henrik NT</name>
      </author>
      <author>
        <name>Lee, Christopher T</name>
        <uri>https://orcid.org/0000-0002-0670-2308</uri>
      </author>
      <author>
        <name>Rognes, Marie E</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
      </author>
    </item>
    <item>
      <title>Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy</title>
      <link>https://escholarship.org/uc/item/5zs5k0w6</link>
      <description>We hypothesized that a strategy employing tissue-specific endothelial cells (EC) might facilitate the identification of tissue- or organ-specific vascular functions of ubiquitous metabolites. An unbiased approach was employed to identify water-soluble small molecules with mitogenic activity on choroidal EC. We identified adenosine diphosphate (ADP) as a candidate, following biochemical purification from mouse EL4 lymphoma extracts. ADP stimulated the growth of bovine choroidal EC (BCEC) and other bovine or human eye-derived EC. ADP induced rapid phosphorylation of extracellular signal-regulated kinase in a dose- and time-dependent manner. ADP-induced BCEC proliferation could be blocked by pretreatment with specific antagonists of the purinergic receptor P2Y1 but not with a vascular endothelial growth factor (VEGF) inhibitor, indicating that the EC mitogenic effects of ADP are not mediated by stimulation of the VEGF pathway. Intravitreal administration of ADP expanded the neovascular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5zs5k0w6</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Biswas, Nilima</name>
      </author>
      <author>
        <name>Mori, Tommaso</name>
      </author>
      <author>
        <name>Nagaraj, Naresh Kumar Ragava Chetty</name>
      </author>
      <author>
        <name>Xin, Hong</name>
      </author>
      <author>
        <name>Diemer, Tanja</name>
      </author>
      <author>
        <name>Li, Pin</name>
      </author>
      <author>
        <name>Su, Yongxuan</name>
      </author>
      <author>
        <name>Piermarocchi, Carlo</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
    </item>
    <item>
      <title>Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)</title>
      <link>https://escholarship.org/uc/item/4xf9t9nd</link>
      <description>Background: Nivolumab paved a new way in the treatment of patients with recurrent or metastatic (RM) head and neck squamous cell carcinoma (RM-HNSCC). However, the limited rates of long-term survivors (&amp;lt; 20%) demand a robust prognostic biomarker. This nationwide multi-centric prospective study aimed to identify a plasma exosome (PEX) mRNA signature, which serves as a companion diagnostic of nivolumab and provides a biological clue to develop effective therapies for a majority of non-survivors.
Methods: Pre-treatment plasmas (&lt;i&gt;N&lt;/i&gt; = 104) of RM-HNSCC patients were subjected to comprehensive PEX mRNA analyses for prognostic marker discovery and validation. In parallel, paired treatment-naïve tumor and plasma samples (&lt;i&gt;N&lt;/i&gt; = 20) were assayed to elucidate biological implications of the PEX mRNA signature.
Results: Assays for pre-treatment blood samples (&lt;i&gt;N&lt;/i&gt; = 104) demonstrated that a combination of 6 candidate PEX mRNAs plus neutrophil-to-lymphocyte ratio precisely...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4xf9t9nd</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Toh, Satoshi</name>
      </author>
      <author>
        <name>Murakami, Taku</name>
      </author>
      <author>
        <name>Nakano, Takafumi</name>
      </author>
      <author>
        <name>Hongo, Takahiro</name>
      </author>
      <author>
        <name>Matsuo, Mioko</name>
      </author>
      <author>
        <name>Hashimoto, Kazuki</name>
      </author>
      <author>
        <name>Sugasawa, Masashi</name>
      </author>
      <author>
        <name>Yamazaki, Keisuke</name>
      </author>
      <author>
        <name>Ueki, Yushi</name>
      </author>
      <author>
        <name>Nakashima, Torahiko</name>
      </author>
      <author>
        <name>Uryu, Hideoki</name>
      </author>
      <author>
        <name>Ono, Takeharu</name>
      </author>
      <author>
        <name>Umeno, Hirohito</name>
      </author>
      <author>
        <name>Ueda, Tsutomu</name>
      </author>
      <author>
        <name>Kano, Satoshi</name>
      </author>
      <author>
        <name>Tsukahara, Kiyoaki</name>
      </author>
      <author>
        <name>Watanabe, Akihito</name>
      </author>
      <author>
        <name>Ota, Ichiro</name>
      </author>
      <author>
        <name>Monden, Nobuya</name>
      </author>
      <author>
        <name>Iwae, Shigemichi</name>
      </author>
      <author>
        <name>Maruo, Takashi</name>
      </author>
      <author>
        <name>Asada, Yukinori</name>
      </author>
      <author>
        <name>Hanai, Nobuhiro</name>
      </author>
      <author>
        <name>Sano, Daisuke</name>
      </author>
      <author>
        <name>Ozawa, Hiroyuki</name>
      </author>
      <author>
        <name>Asakage, Takahiro</name>
      </author>
      <author>
        <name>Fukusumi, Takahito</name>
      </author>
      <author>
        <name>Masuda, Muneyuki</name>
      </author>
    </item>
    <item>
      <title>Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB</title>
      <link>https://escholarship.org/uc/item/90m6q5tk</link>
      <description>The Arf GTPase family is involved in a wide range of cellular regulation including membrane trafficking and organelle–structure assembly. Here, we have generated a proximity interaction network for the Arf family using the miniTurboID approach combined with TMT‐based quantitative mass spectrometry. Our interactome confirmed known interactions and identified many novel interactors that provide leads for defining Arf pathway cell biological functions. We explored the unexpected finding that phospholipase D1 (PLD1) preferentially interacts with two closely related but poorly studied Arf family GTPases, ARL11 and ARL14, showing that PLD1 is activated by ARL11/14 and may recruit these GTPases to membrane vesicles, and that PLD1 and ARL11 collaborate to promote macrophage phagocytosis. Moreover, ARL5A and ARL5B were found to interact with and recruit phosphatidylinositol 4‐kinase beta (PI4KB) at trans‐Golgi, thus promoting PI4KB's function in PI4P synthesis and protein secretion.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/90m6q5tk</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Fu‐Long</name>
      </author>
      <author>
        <name>Wu, Zhengming</name>
      </author>
      <author>
        <name>Gao, Yong‐Qi</name>
      </author>
      <author>
        <name>Bowling, Forrest Z</name>
      </author>
      <author>
        <name>Franklin, J Matthew</name>
      </author>
      <author>
        <name>Hu, Chongze</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
        <uri>https://orcid.org/0000-0002-4767-7639</uri>
      </author>
      <author>
        <name>Frohman, Michael A</name>
      </author>
      <author>
        <name>Airola, Michael V</name>
      </author>
      <author>
        <name>Zhou, Huilin</name>
      </author>
      <author>
        <name>Guan, Kun‐Liang</name>
        <uri>https://orcid.org/0000-0003-1892-0174</uri>
      </author>
    </item>
    <item>
      <title>Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis</title>
      <link>https://escholarship.org/uc/item/9cx6s28c</link>
      <description>Until now, Hippo pathway-mediated nucleocytoplasmic translocation has been considered the primary mechanism by which yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) transcriptional coactivators regulate cell proliferation and differentiation via transcriptional enhanced associate domain (TEAD)-mediated target gene expression. In this study, however, we found that TAZ, but not YAP, is associated with the Golgi apparatus in macrophages activated via Toll-like receptor ligands during the resolution phase of inflammation. Golgi-associated TAZ enhanced vesicle trafficking and secretion of proinflammatory cytokines in M1 macrophage independent of the Hippo pathway. Depletion of TAZ in tumor-associated macrophages promoted tumor growth by suppressing the recruitment of tumor-infiltrating lymphocytes. Moreover, in a diet-induced metabolic dysfunction-associated steatohepatitis model, macrophage-specific deletion of TAZ ameliorated liver inflammation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9cx6s28c</guid>
      <pubDate>Fri, 31 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Park, So Yeon</name>
      </author>
      <author>
        <name>Ju, Sungeun</name>
      </author>
      <author>
        <name>Lee, Jaehoon</name>
      </author>
      <author>
        <name>Kim, Hwa-Ryeon</name>
      </author>
      <author>
        <name>Sub, Yujin</name>
      </author>
      <author>
        <name>Park, Dong Jin</name>
      </author>
      <author>
        <name>Park, Seyeon</name>
      </author>
      <author>
        <name>Kwon, Doru</name>
      </author>
      <author>
        <name>Kang, Hyeok Gu</name>
      </author>
      <author>
        <name>Shin, Ji Eun</name>
      </author>
      <author>
        <name>Kim, Dong Hyeon</name>
      </author>
      <author>
        <name>Paik, Ji Eun</name>
      </author>
      <author>
        <name>Cho, Seok Chan</name>
      </author>
      <author>
        <name>Shim, Hyeran</name>
      </author>
      <author>
        <name>Kim, Young-Joon</name>
      </author>
      <author>
        <name>Guan, Kun-Liang</name>
        <uri>https://orcid.org/0000-0003-1892-0174</uri>
      </author>
      <author>
        <name>Chun, Kyung-Hee</name>
      </author>
      <author>
        <name>Choi, Junjeong</name>
      </author>
      <author>
        <name>Ha, Sang-Jun</name>
      </author>
      <author>
        <name>Gee, Heon Yung</name>
      </author>
      <author>
        <name>Roe, Jae-Seok</name>
      </author>
      <author>
        <name>Lee, Han-Woong</name>
      </author>
      <author>
        <name>Park, Seung-Yeol</name>
      </author>
      <author>
        <name>Park, Hyun Woo</name>
      </author>
    </item>
    <item>
      <title>Development of an Open-Source Dataset of Flat-Mounted Images for the Murine Oxygen–Induced Retinopathy Model of Ischemic Retinopathy</title>
      <link>https://escholarship.org/uc/item/3gz9n4z9</link>
      <description>Purpose: To describe an open-source dataset of flat-mounted retinal images and vessel segmentations from mice subject to the oxygen-induced retinopathy (OIR) model.
Methods: Flat-mounted retinal images from mice killed at postnatal days 12 (P12), P17, and P25 used in prior OIR studies were compiled. Mice subjected to normoxic conditions were killed at P12, P17, and P25, and their retinas were flat-mounted for imaging. Major blood vessels from the OIR images were manually segmented by four graders (JSC, HKR, KBL, JM), with cross-validation performed to ensure similar grading.
Results: Overall, 1170 images were included in this dataset. Of these images, 111 were of normoxic mice retina, and 1048 were mice subject to OIR. The majority of images from OIR mice were obtained at P17. The 50 images obtained from an external dataset, OIRSeg, did not have age labels. All images were manually segmented and used in the training or testing of a previously published deep learning algorithm.
Conclusions:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3gz9n4z9</guid>
      <pubDate>Fri, 31 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Marra, Kyle V</name>
      </author>
      <author>
        <name>Chen, Jimmy S</name>
      </author>
      <author>
        <name>Robles-Holmes, Hailey K</name>
      </author>
      <author>
        <name>Ly, Kristine B</name>
      </author>
      <author>
        <name>Miller, Joseph</name>
      </author>
      <author>
        <name>Wei, Guoqin</name>
      </author>
      <author>
        <name>Aguilar, Edith</name>
      </author>
      <author>
        <name>Bucher, Felicitas</name>
      </author>
      <author>
        <name>Ideguchi, Yoichi</name>
      </author>
      <author>
        <name>Kalaw, Fritz Gerald P</name>
        <uri>https://orcid.org/0000-0002-3940-2272</uri>
      </author>
      <author>
        <name>Lin, Andrew C</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
      <author>
        <name>Campbell, J Peter</name>
      </author>
      <author>
        <name>Friedlander, Martin</name>
      </author>
      <author>
        <name>Nudleman, Eric</name>
      </author>
    </item>
    <item>
      <title>Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase</title>
      <link>https://escholarship.org/uc/item/3qr9d1cg</link>
      <description>Discovered in the 1920s, cytochrome &lt;i&gt;bd&lt;/i&gt; is a terminal oxidase that has received renewed attention as a drug target since its atomic structure was first determined in 2016. Only found in prokaryotes, we study it here as a drug target for &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; (&lt;i&gt;Mtb&lt;/i&gt;). Most previous drug discovery efforts toward cytochrome &lt;i&gt;bd&lt;/i&gt; have involved analogues of the canonical substrate quinone, known as Aurachin D. Here, we report six new cytochrome &lt;i&gt;bd&lt;/i&gt; inhibitor scaffolds determined from a computational screen and confirmed on target activity through &lt;i&gt;in vitro&lt;/i&gt; testing. These scaffolds provide new avenues for lead optimization toward &lt;i&gt;Mtb&lt;/i&gt; therapeutics.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3qr9d1cg</guid>
      <pubDate>Wed, 29 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Seitz, Christian</name>
      </author>
      <author>
        <name>Ahn, Surl-Hee</name>
      </author>
      <author>
        <name>Wei, Haixin</name>
      </author>
      <author>
        <name>Kyte, Matson</name>
      </author>
      <author>
        <name>Cook, Gregory M</name>
      </author>
      <author>
        <name>Krause, Kurt L</name>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
    </item>
    <item>
      <title>Membrane mechanics dictate axonal pearls-on-a-string morphology and function</title>
      <link>https://escholarship.org/uc/item/1v9873q3</link>
      <description>Axons are ultrathin membrane cables that are specialized for the conduction of action potentials. Although their diameter is variable along their length, how their morphology is determined is unclear. Here, we demonstrate that unmyelinated axons of the mouse central nervous system have nonsynaptic, nanoscopic varicosities ~200 nm in diameter repeatedly along their length interspersed with a thin cable ~60 nm in diameter like pearls-on-a-string. In silico modeling suggests that this axon nanopearling can be explained by membrane mechanical properties. Treatments disrupting membrane properties, such as hyper- or hypotonic solutions, cholesterol removal and nonmuscle myosin II inhibition, alter axon nanopearling, confirming the role of membrane mechanics in determining axon morphology. Furthermore, neuronal activity modulates plasma membrane cholesterol concentration, leading to changes in axon nanopearls and causing slowing of action potential conduction velocity. These data reveal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1v9873q3</guid>
      <pubDate>Tue, 21 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Griswold, Jacqueline M</name>
      </author>
      <author>
        <name>Bonilla-Quintana, Mayte</name>
      </author>
      <author>
        <name>Pepper, Renee</name>
      </author>
      <author>
        <name>Lee, Christopher T</name>
        <uri>https://orcid.org/0000-0002-0670-2308</uri>
      </author>
      <author>
        <name>Raychaudhuri, Sumana</name>
      </author>
      <author>
        <name>Ma, Siyi</name>
      </author>
      <author>
        <name>Gan, Quan</name>
      </author>
      <author>
        <name>Syed, Sarah</name>
      </author>
      <author>
        <name>Zhu, Cuncheng</name>
        <uri>https://orcid.org/0000-0003-1373-3492</uri>
      </author>
      <author>
        <name>Bell, Miriam</name>
      </author>
      <author>
        <name>Suga, Mitsuo</name>
      </author>
      <author>
        <name>Yamaguchi, Yuuki</name>
      </author>
      <author>
        <name>Chéreau, Ronan</name>
      </author>
      <author>
        <name>Nägerl, U Valentin</name>
      </author>
      <author>
        <name>Knott, Graham</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
        <uri>https://orcid.org/0000-0001-5953-4347</uri>
      </author>
      <author>
        <name>Watanabe, Shigeki</name>
      </author>
    </item>
    <item>
      <title>Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy</title>
      <link>https://escholarship.org/uc/item/7854834r</link>
      <description>Eicosanoids are key players in inflammatory diseases and cancer. Targeting their production by inhibiting Group IVA cytosolic phospholipase A2 (cPLA2α) offers a promising approach for cancer therapy. In this study, we synthesize a second generation of thiazolyl ketone inhibitors of cPLA2α starting with compound GK470 (AVX235) and test their in vitro and cellular activities. We identify a more potent and selective lead molecule, GK420 (AVX420), which we test in parallel with AVX235 and a structurally unrelated compound, AVX002 for inhibition of cell viability across a panel of cancer cell lines. From this, we show that activity of polycomb group repressive complex 2 is a key molecular determinant of sensitivity to cPLA2α inhibition, while resistance depends on antioxidant response pathways. Consistent with these results, we show that elevated intracellular reactive oxygen species and activating transcription factor 4 target gene expression precede cell death in AVX420-sensitive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7854834r</guid>
      <pubDate>Mon, 20 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ashcroft, Felicity J</name>
      </author>
      <author>
        <name>Bourboula, Asimina</name>
      </author>
      <author>
        <name>Mahammad, Nur</name>
      </author>
      <author>
        <name>Barbayianni, Efrosini</name>
      </author>
      <author>
        <name>Feuerherm, Astrid J</name>
      </author>
      <author>
        <name>Nguyen, Thanh Thuy</name>
      </author>
      <author>
        <name>Hayashi, Daiki</name>
      </author>
      <author>
        <name>Kokotou, Maroula G</name>
      </author>
      <author>
        <name>Alevizopoulos, Konstantinos</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
      <author>
        <name>Kokotos, George</name>
      </author>
      <author>
        <name>Johansen, Berit</name>
      </author>
    </item>
    <item>
      <title>Transcriptomics of SGLT2-positive early proximal tubule segments in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism</title>
      <link>https://escholarship.org/uc/item/8v25k2zs</link>
      <description>SGLT2 inhibitors and GLP1 receptor agonists have kidney protective effects. By combining immunostaining-guided laser capture microdissection and RNA sequencing, the study established how the gene expression profile changes in SGLT2-positive proximal tubule cells in response to type 1 Akita diabetes and to pharmacological intervention by SGLT2 inhibition or GLP1R agonism and genetic deletion of SGLT1. The data also indicate genes unresponsive to those treatments that may include new therapeutical candidates.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8v25k2zs</guid>
      <pubDate>Thu, 16 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Kim, Young Chul</name>
        <uri>https://orcid.org/0000-0002-6782-2186</uri>
      </author>
      <author>
        <name>Das, Vivek</name>
        <uri>https://orcid.org/0000-0003-0614-0373</uri>
      </author>
      <author>
        <name>Kanoo, Sadhana</name>
      </author>
      <author>
        <name>Yao, Huazhen</name>
      </author>
      <author>
        <name>Stanford, Stephanie M</name>
      </author>
      <author>
        <name>Bottini, Nunzio</name>
        <uri>https://orcid.org/0000-0001-9025-7501</uri>
      </author>
      <author>
        <name>Karihaloo, Anil</name>
      </author>
      <author>
        <name>Vallon, Volker</name>
        <uri>https://orcid.org/0000-0002-9211-2063</uri>
      </author>
    </item>
    <item>
      <title>YAP-driven malignant reprogramming of oral epithelial stem cells at single cell resolution</title>
      <link>https://escholarship.org/uc/item/191702zj</link>
      <description>Tumor initiation represents the first step in tumorigenesis during which normal progenitor cells undergo cell fate transition to cancer. Capturing this process as it occurs in vivo, however, remains elusive. Here we employ spatiotemporally controlled oncogene activation and tumor suppressor inhibition together with multiomics to unveil the processes underlying oral epithelial progenitor cell reprogramming into tumor initiating cells at single cell resolution. Tumor initiating cells displayed a distinct stem-like state, defined by aberrant proliferative, hypoxic, squamous differentiation, and partial epithelial to mesenchymal invasive gene programs. YAP-mediated tumor initiating cell programs included activation of oncogenic transcriptional networks and mTOR signaling, and recruitment of myeloid cells to the invasive front contributing to tumor infiltration. Tumor initiating cell transcriptional programs are conserved in human head and neck cancer and associated with poor patient...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/191702zj</guid>
      <pubDate>Thu, 16 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Faraji, Farhoud</name>
      </author>
      <author>
        <name>Ramirez, Sydney I</name>
      </author>
      <author>
        <name>Clubb, Lauren M</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Burghi, Valeria</name>
      </author>
      <author>
        <name>Hoang, Thomas S</name>
      </author>
      <author>
        <name>Officer, Adam</name>
      </author>
      <author>
        <name>Anguiano Quiroz, Paola Y</name>
      </author>
      <author>
        <name>Galloway, William MG</name>
      </author>
      <author>
        <name>Mikulski, Zbigniew</name>
      </author>
      <author>
        <name>Medetgul-Ernar, Kate</name>
      </author>
      <author>
        <name>Marangoni, Pauline</name>
      </author>
      <author>
        <name>Jones, Kyle B</name>
      </author>
      <author>
        <name>Cao, Yuwei</name>
        <uri>https://orcid.org/0009-0000-4119-4399</uri>
      </author>
      <author>
        <name>Molinolo, Alfredo A</name>
      </author>
      <author>
        <name>Kim, Kenneth</name>
      </author>
      <author>
        <name>Sakaguchi, Kanako</name>
      </author>
      <author>
        <name>Califano, Joseph A</name>
      </author>
      <author>
        <name>Smith, Quinton</name>
      </author>
      <author>
        <name>Goren, Alon</name>
      </author>
      <author>
        <name>Klein, Ophir D</name>
      </author>
      <author>
        <name>Tamayo, Pablo</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
    </item>
    <item>
      <title>Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer</title>
      <link>https://escholarship.org/uc/item/0bq0p8k9</link>
      <description>BackgroundBasket clinical trials targeting the KRASG12C-mutation in solid tumors have shown initial promise, including in orphan KRASG12C head and neck cancer (HNC). However, development of resistance to KRASG12C-mutant-specific inhibitors (KRASG12Ci) remains a major obstacle. Here, we investigated the intrinsic (tumor-cell autonomus) and tumor-microenvironment (TME) mechanisms of resistance to the KRASG12Ci—MRTX849 and AMG510 in a unique syngenic murine KRASG12C-mutated HNC cell line.MethodsWestern-blotting was used for protein abundance and activation, overexpression, and ligand activation studies to verify the intrinsic mechanism of resistance to KRASG12Ci in KRASG12C-mutated HNC cell line, 4NQO-L. In vitro KRASG12C-acquired-resistant cells were developed from 4NQO-L (4NQO-L-AcR). MRTX849/lapatinib combination efficacy, and CD8+ T-cells depletion, were assessed in C57BL/6&amp;nbsp;J mice and supplementation of anti-PD-1 (αPD-1) to MRTX849/lapatinib was also performed in 4NQO-L–...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0bq0p8k9</guid>
      <pubDate>Fri, 10 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Novoplansky, Ofra</name>
      </author>
      <author>
        <name>Jagadeeshan, Sankar</name>
      </author>
      <author>
        <name>Prasad, Manu</name>
      </author>
      <author>
        <name>Yegodayev, Ksenia M</name>
      </author>
      <author>
        <name>Marripati, Divyasree</name>
      </author>
      <author>
        <name>Shareb, Raghda Abu</name>
      </author>
      <author>
        <name>Greenshpan, Yariv</name>
      </author>
      <author>
        <name>Mathukkada, Sooraj</name>
      </author>
      <author>
        <name>Ben-Lulu, Talal</name>
      </author>
      <author>
        <name>Bhattacharya, Baisali</name>
      </author>
      <author>
        <name>Porgador, Angel</name>
      </author>
      <author>
        <name>Kong, Dexin</name>
      </author>
      <author>
        <name>Brägelmann, Johannes</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Elkabets, Moshe</name>
      </author>
    </item>
    <item>
      <title>PERIOD phosphorylation leads to feedback inhibition of CK1 activity to control circadian period</title>
      <link>https://escholarship.org/uc/item/3250r6sc</link>
      <description>PERIOD (PER) and Casein Kinase 1δ regulate circadian rhythms through a phosphoswitch that controls PER stability and repressive activity in the molecular clock. CK1δ phosphorylation of the familial advanced sleep phase (FASP) serine cluster embedded within the Casein Kinase 1 binding domain (CK1BD) of mammalian PER1/2 inhibits its activity on phosphodegrons to stabilize PER and extend circadian period. Here, we show that the phosphorylated FASP region (pFASP) of PER2 directly interacts with and inhibits CK1δ. Co-crystal structures in conjunction with molecular dynamics simulations reveal how pFASP phosphoserines dock into conserved anion binding sites near the active site of CK1δ. Limiting phosphorylation of the FASP serine cluster reduces product inhibition, decreasing PER2 stability and shortening circadian period in human cells. We found that Drosophila PER also regulates CK1δ via feedback inhibition through the phosphorylated PER-Short domain, revealing a conserved mechanism...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3250r6sc</guid>
      <pubDate>Wed, 8 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Philpott, Jonathan M</name>
      </author>
      <author>
        <name>Freeberg, Alfred M</name>
      </author>
      <author>
        <name>Park, Jiyoung</name>
      </author>
      <author>
        <name>Lee, Kwangjun</name>
      </author>
      <author>
        <name>Ricci, Clarisse G</name>
      </author>
      <author>
        <name>Hunt, Sabrina R</name>
      </author>
      <author>
        <name>Narasimamurthy, Rajesh</name>
      </author>
      <author>
        <name>Segal, David H</name>
      </author>
      <author>
        <name>Robles, Rafael</name>
      </author>
      <author>
        <name>Cai, Yao</name>
      </author>
      <author>
        <name>Tripathi, Sarvind</name>
        <uri>https://orcid.org/0000-0002-6959-0577</uri>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
      <author>
        <name>Virshup, David M</name>
      </author>
      <author>
        <name>Chiu, Joanna C</name>
      </author>
      <author>
        <name>Lee, Choogon</name>
      </author>
      <author>
        <name>Partch, Carrie L</name>
        <uri>https://orcid.org/0000-0002-4677-2861</uri>
      </author>
    </item>
    <item>
      <title>Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment</title>
      <link>https://escholarship.org/uc/item/7k23j2jx</link>
      <description>Chemotherapies remain standard therapy for cancers but have limited efficacy and cause significant side effects, highlighting the need for targeted approaches. In the progression of cancer, tumors increase matrix metalloproteinase (MMP) activity. Leveraging and therapeutically redirecting tumor MMPs through activatable cell-penetrating peptide (ACPP) technology offers new approaches for tumor-selective drug delivery and for studying how drug payloads engage the tumor immune microenvironment. ACPPs are biosensing peptides consisting of a drug-conjugated polycationic cell-penetrating peptide masked by an autoinhibitory polyanionic peptide through an interlinking peptide linker. Since tumors overexpress MMPs, ACPP tumor-targeting is achieved using an MMP cleavable linker. Monomethyl auristatin E (MMAE) is a potent anti-tubulin and common drug payload in antibody drug conjugates; however there are limited pre-clinical studies on how this clinically effective drug modulates the interplay...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7k23j2jx</guid>
      <pubDate>Sat, 4 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mortaja, Mahsa</name>
      </author>
      <author>
        <name>Cheng, Marcus M</name>
      </author>
      <author>
        <name>Ali, Alina</name>
      </author>
      <author>
        <name>Lesperance, Jacqueline</name>
      </author>
      <author>
        <name>Hingorani, Dina V</name>
      </author>
      <author>
        <name>Allevato, Mike M</name>
      </author>
      <author>
        <name>Dhawan, Kanika</name>
        <uri>https://orcid.org/0000-0002-6267-0312</uri>
      </author>
      <author>
        <name>Camargo, Maria F</name>
      </author>
      <author>
        <name>McKay, Rana R</name>
      </author>
      <author>
        <name>Adams, Stephen R</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Advani, Sunil J</name>
      </author>
    </item>
    <item>
      <title>Role of the αC-β4 loop in protein kinase structure and dynamics</title>
      <link>https://escholarship.org/uc/item/0bk1m9dz</link>
      <description>Although the αC-β4 loop is a stable feature of all protein kinases, the importance of this motif as a conserved element of secondary structure, as well as its links to the hydrophobic architecture of the kinase core, has been underappreciated. We first review the motif and then describe how it is linked to the hydrophobic spine architecture of the kinase core, which we first discovered using a computational tool, local spatial Pattern (LSP) alignment. Based on NMR predictions that a mutation in this motif abolishes the synergistic high-affinity binding of ATP and a pseudo substrate inhibitor, we used LSP to interrogate the F100A mutant. This comparison highlights the importance of the αC-β4 loop and key residues at the interface between the N- and C-lobes. In addition, we delved more deeply into the structure of the apo C-subunit, which lacks ATP. While apo C-subunit showed no significant changes in backbone dynamics of the αC-β4 loop, we found significant differences in the side...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0bk1m9dz</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Jian</name>
        <uri>https://orcid.org/0000-0002-8031-9462</uri>
      </author>
      <author>
        <name>Jonniya, Nisha A</name>
      </author>
      <author>
        <name>Hirakis, Sophia P</name>
      </author>
      <author>
        <name>Olivieri, Cristina</name>
      </author>
      <author>
        <name>Veglia, Gianluigi</name>
      </author>
      <author>
        <name>Kornev, Alexandr P</name>
      </author>
      <author>
        <name>Taylor, Susan S</name>
      </author>
    </item>
    <item>
      <title>Hippo pathway in cancer cells induces NCAM1+αSMA+ fibroblasts to modulate tumor microenvironment</title>
      <link>https://escholarship.org/uc/item/37425225</link>
      <description>Cancer cells adeptly manipulate the tumor microenvironment (TME) to evade host antitumor immunity. However, the role of cancer cell-intrinsic signaling in shaping the immunosuppressive TME remains unclear. Here, we found that the Hippo pathway in cancer cells orchestrates the TME by influencing the composition of cancer-associated fibroblasts (CAFs). In a 4T1 mouse breast cancer model, Hippo pathway kinases, large tumor suppressor 1 and 2 (LATS1/2), promoted the formation of neural cell adhesion molecule 1 (NCAM1)+alpha-smooth muscle actin (αSMA)+ CAFs expressing the transforming growth factor-β, which is associated with T cell inactivation and dysfunction. Depletion of LATS1/2 in cancer cells resulted in a less immunosuppressive TME, indicated by the reduced proportions of NCAM1+αSMA+ CAFs and dysfunctional T cells. Notably, similar Hippo pathway-induced NCAM1+αSMA+ CAFs were observed in human breast cancer, highlighting the potential of TME-manipulating strategies to reduce...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/37425225</guid>
      <pubDate>Mon, 16 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Thinyakul, Chanida</name>
      </author>
      <author>
        <name>Sakamoto, Yasuhisa</name>
      </author>
      <author>
        <name>Shimoda, Mayuko</name>
      </author>
      <author>
        <name>Liu, Yanliang</name>
      </author>
      <author>
        <name>Thongchot, Suyanee</name>
      </author>
      <author>
        <name>Reda, Omnia</name>
      </author>
      <author>
        <name>Nita, Akihiro</name>
      </author>
      <author>
        <name>Sakamula, Romgase</name>
      </author>
      <author>
        <name>Sampattavanich, Somponnat</name>
      </author>
      <author>
        <name>Maeda, Ayato</name>
      </author>
      <author>
        <name>Chunthaboon, Paweenapon</name>
      </author>
      <author>
        <name>Nduru, David</name>
      </author>
      <author>
        <name>Niimura, Mayumi</name>
      </author>
      <author>
        <name>Kanamori, Yohei</name>
      </author>
      <author>
        <name>Thuwajit, Peti</name>
      </author>
      <author>
        <name>Nakayama, Keiichi I</name>
      </author>
      <author>
        <name>Guan, Kun-Liang</name>
        <uri>https://orcid.org/0000-0003-1892-0174</uri>
      </author>
      <author>
        <name>Satou, Yorifumi</name>
      </author>
      <author>
        <name>Thuwajit, Chanitra</name>
      </author>
      <author>
        <name>Moroishi, Toshiro</name>
      </author>
    </item>
    <item>
      <title>An optimized fractionation method reveals insulin-induced membrane surface localization of GLUT1 to increase glycolysis in LβT2 cells</title>
      <link>https://escholarship.org/uc/item/4p06c1gs</link>
      <description>Insulin is an important regulator of whole-body glucose homeostasis. In insulin sensitive tissues such as muscle and adipose, insulin induces the translocation of glucose transporter 4 (GLUT4) to the cell membrane, thereby increasing glucose uptake. However, insulin also signals in tissues that are not generally associated with glucose homeostasis. In the human reproductive endocrine axis, hyperinsulinemia suppresses the secretion of gonadotropins from gonadotrope cells of the anterior pituitary, thereby linking insulin dysregulation to suboptimal reproductive health. In the mouse, gonadotropes express the insulin receptor which has the canonical signaling response of IRS, AKT, and mTOR activation. However, the functional outcomes of insulin action on gonadotropes are unclear. Here, we demonstrate through use of an optimized cell fractionation protocol that insulin stimulation of the LβT2 gonadotropic cell line results in the unexpected translocation of GLUT1 to the plasma membrane....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4p06c1gs</guid>
      <pubDate>Sun, 8 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Molinar-Inglis, Olivia</name>
      </author>
      <author>
        <name>Wiggins, Kiara</name>
      </author>
      <author>
        <name>Varma, Anjali</name>
      </author>
      <author>
        <name>Del Mundo, Zena</name>
      </author>
      <author>
        <name>Adame, Jose M</name>
      </author>
      <author>
        <name>Cozzo, Alyssa</name>
      </author>
      <author>
        <name>Muñoz, Oscar</name>
      </author>
      <author>
        <name>Le, Uyen-Vy</name>
      </author>
      <author>
        <name>Trinh, Davina</name>
      </author>
      <author>
        <name>Garcia, Alexis C</name>
      </author>
      <author>
        <name>Cisneros-Aguirre, Metztli</name>
      </author>
      <author>
        <name>Ramirez, Monica L Gonzalez</name>
      </author>
      <author>
        <name>Keyes, Jeremiah</name>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
      <author>
        <name>Lawson, Mark A</name>
        <uri>https://orcid.org/0000-0003-2303-3086</uri>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Nicholas, Dequina A</name>
      </author>
    </item>
    <item>
      <title>Molecular Spies in Action: Genetically Encoded Fluorescent Biosensors Light up Cellular Signals</title>
      <link>https://escholarship.org/uc/item/9vm5290q</link>
      <description>Cellular function is controlled through intricate networks of signals, which lead to the myriad pathways governing cell fate. Fluorescent biosensors have enabled the study of these signaling pathways in living systems across temporal and spatial scales. Over the years there has been an explosion in the number of fluorescent biosensors, as they have become available for numerous targets, utilized across spectral space, and suited for various imaging techniques. To guide users through this extensive biosensor landscape, we discuss critical aspects of fluorescent proteins for consideration in biosensor development, smart tagging strategies, and the historical and recent biosensors of various types, grouped by target, and with a focus on the design and recent applications of these sensors in living systems.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9vm5290q</guid>
      <pubDate>Sat, 7 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gest, Anneliese MM</name>
      </author>
      <author>
        <name>Sahan, Ayse Z</name>
      </author>
      <author>
        <name>Zhong, Yanghao</name>
      </author>
      <author>
        <name>Lin, Wei</name>
      </author>
      <author>
        <name>Mehta, Sohum</name>
        <uri>https://orcid.org/0000-0003-4764-8579</uri>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
    </item>
    <item>
      <title>Monocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state</title>
      <link>https://escholarship.org/uc/item/5sv7649t</link>
      <description>Current evidence suggests that ontogeny may account for the functional heterogeneity of some tissue macrophages, but not others. Here, we asked whether developmental origin drives different functions of skin Langerhans cells (LCs), an embryo-derived mononuclear phagocyte with features of both tissue macrophages and dendritic cells. Using time-course analyses, bone marrow chimeras, and fate tracing models, we found that the complete elimination of embryo-derived LCs at steady state results in their repopulation from circulating monocytes. However, monocyte-derived LCs inefficiently replenished the epidermal niche. Instead, these cells preferentially migrated to skin-draining lymph nodes. Mechanistically, we show that the enhanced migratory capability of monocyte-derived LCs is associated with higher expression of CD207/Langerin, a C-type lectin involved in the capture of skin microbes. Our data demonstrate that ontogeny plays a role in the migratory behavior of epidermal LCs.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5sv7649t</guid>
      <pubDate>Sat, 7 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Raquer-McKay, Hayley M</name>
      </author>
      <author>
        <name>Maqueda-Alfaro, Raul A</name>
      </author>
      <author>
        <name>Saravanan, Sanjana</name>
      </author>
      <author>
        <name>Hornero, Rebeca Arroyo</name>
      </author>
      <author>
        <name>Clausen, Björn E</name>
      </author>
      <author>
        <name>Gottfried-Blackmore, Andres</name>
      </author>
      <author>
        <name>Idoyaga, Juliana</name>
        <uri>https://orcid.org/0000-0002-4430-8862</uri>
      </author>
    </item>
    <item>
      <title>Homeocurvature adaptation of phospholipids to pressure in deep-sea invertebrates</title>
      <link>https://escholarship.org/uc/item/4wh3181r</link>
      <description>Hydrostatic pressure increases with depth in the ocean, but little is known about the molecular bases of biological pressure tolerance. We describe a mode of pressure adaptation in comb jellies (ctenophores) that also constrains these animals' depth range. Structural analysis of deep-sea ctenophore lipids shows that they form a nonbilayer phase at pressures under which the phase is not typically stable. Lipidomics and all-atom simulations identified phospholipids with strong negative spontaneous curvature, including plasmalogens, as a hallmark of deep-adapted membranes that causes this phase behavior. Synthesis of plasmalogens enhanced pressure tolerance in &lt;i&gt;Escherichia coli&lt;/i&gt;, whereas low-curvature lipids had the opposite effect. Imaging of ctenophore tissues indicated that the disintegration of deep-sea animals when decompressed could be driven by a phase transition in their phospholipid membranes.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wh3181r</guid>
      <pubDate>Sat, 7 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Winnikoff, Jacob R</name>
      </author>
      <author>
        <name>Milshteyn, Daniel</name>
      </author>
      <author>
        <name>Vargas-Urbano, Sasiri J</name>
      </author>
      <author>
        <name>Pedraza-Joya, Miguel A</name>
      </author>
      <author>
        <name>Armando, Aaron M</name>
      </author>
      <author>
        <name>Quehenberger, Oswald</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>Sodt, Alexander</name>
      </author>
      <author>
        <name>Gillilan, Richard E</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
      <author>
        <name>Lyman, Edward</name>
      </author>
      <author>
        <name>Haddock, Steven HD</name>
      </author>
      <author>
        <name>Budin, Itay</name>
        <uri>https://orcid.org/0000-0001-9706-4294</uri>
      </author>
    </item>
    <item>
      <title>Functional annotation of the Hippo pathway somatic mutations in human cancers</title>
      <link>https://escholarship.org/uc/item/30x151vk</link>
      <description>The Hippo pathway is commonly altered in cancer initiation and progression; however, exactly how this pathway becomes dysregulated to promote human cancer development remains unclear. Here we analyze the Hippo somatic mutations in the human cancer genome and functionally annotate their roles in targeting the Hippo pathway. We identify a total of 85 loss-of-function (LOF) missense mutations for Hippo pathway genes and elucidate their underlying mechanisms. Interestingly, we reveal zinc-finger domain as an integral structure for MOB1 function, whose LOF mutations in head and neck cancer promote tumor growth. Moreover, the schwannoma/meningioma-derived NF2 LOF mutations not only inhibit its tumor suppressive function in the Hippo pathway, but also gain an oncogenic role for NF2 by activating the VANGL-JNK pathway. Collectively, our study not only offers a rich somatic mutation resource for investigating the Hippo pathway in human cancers, but also provides a molecular basis for Hippo-based...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/30x151vk</guid>
      <pubDate>Mon, 2 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Han, Han</name>
      </author>
      <author>
        <name>Huang, Zhen</name>
      </author>
      <author>
        <name>Xu, Congsheng</name>
      </author>
      <author>
        <name>Seo, Gayoung</name>
      </author>
      <author>
        <name>An, Jeongmin</name>
        <uri>https://orcid.org/0000-0002-2357-0941</uri>
      </author>
      <author>
        <name>Yang, Bing</name>
      </author>
      <author>
        <name>Liu, Yuhan</name>
      </author>
      <author>
        <name>Lan, Tian</name>
      </author>
      <author>
        <name>Yan, Jiachen</name>
      </author>
      <author>
        <name>Ren, Shanshan</name>
      </author>
      <author>
        <name>Xu, Yue</name>
      </author>
      <author>
        <name>Xiao, Di</name>
      </author>
      <author>
        <name>Yan, Jonathan K</name>
      </author>
      <author>
        <name>Ahn, Claire</name>
      </author>
      <author>
        <name>Fishman, Dmitry A</name>
      </author>
      <author>
        <name>Meng, Zhipeng</name>
      </author>
      <author>
        <name>Guan, Kun-Liang</name>
        <uri>https://orcid.org/0000-0003-1892-0174</uri>
      </author>
      <author>
        <name>Qi, Ruxi</name>
      </author>
      <author>
        <name>Luo, Ray</name>
        <uri>https://orcid.org/0000-0002-6346-8271</uri>
      </author>
      <author>
        <name>Wang, Wenqi</name>
      </author>
    </item>
    <item>
      <title>Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers</title>
      <link>https://escholarship.org/uc/item/9r04p88k</link>
      <description>BackgroundIntratumor heterogeneity (ITH) in microsatellite instability-high (MSI-H) colorectal cancer (CRC) has been poorly studied. We aimed to clarify how the ITH of MSI-H CRCs is generated in cancer evolution and how immune selective pressure affects ITH.MethodsWe reanalyzed public whole-exome sequencing data on 246 MSI-H CRCs. In addition, we performed a multi-region analysis from 6 MSI-H CRCs. To verify the process of subclonal immune escape accumulation, a novel computational model of cancer evolution under immune pressure was developed.ResultsOur analysis presented the enrichment of functional genomic alterations in antigen-presentation machinery (APM). Associative analysis of neoantigens indicated the generation of immune escape mechanisms via HLA alterations. Multiregion analysis revealed the clonal acquisition of driver mutations and subclonal accumulation of APM defects in MSI-H CRCs. Examination of variant allele frequencies demonstrated that subclonal mutations tend...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9r04p88k</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Kobayashi, Yuta</name>
      </author>
      <author>
        <name>Niida, Atsushi</name>
      </author>
      <author>
        <name>Nagayama, Satoshi</name>
      </author>
      <author>
        <name>Saeki, Koichi</name>
      </author>
      <author>
        <name>Haeno, Hiroshi</name>
      </author>
      <author>
        <name>Takahashi, Kazuki K</name>
      </author>
      <author>
        <name>Hayashi, Shuto</name>
      </author>
      <author>
        <name>Ozato, Yuki</name>
      </author>
      <author>
        <name>Saito, Hideyuki</name>
      </author>
      <author>
        <name>Hasegawa, Takanori</name>
      </author>
      <author>
        <name>Nakamura, Hiromi</name>
      </author>
      <author>
        <name>Tobo, Taro</name>
      </author>
      <author>
        <name>Kitagawa, Akihiro</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Shimizu, Dai</name>
      </author>
      <author>
        <name>Hirata, Hidenari</name>
      </author>
      <author>
        <name>Hisamatsu, Yuichi</name>
      </author>
      <author>
        <name>Toshima, Takeo</name>
      </author>
      <author>
        <name>Yonemura, Yusuke</name>
      </author>
      <author>
        <name>Masuda, Takaaki</name>
      </author>
      <author>
        <name>Mizuno, Shinichi</name>
      </author>
      <author>
        <name>Kawazu, Masahito</name>
      </author>
      <author>
        <name>Kohsaka, Shinji</name>
      </author>
      <author>
        <name>Ueno, Toshihide</name>
      </author>
      <author>
        <name>Mano, Hiroyuki</name>
      </author>
      <author>
        <name>Ishihara, Soichiro</name>
      </author>
      <author>
        <name>Uemura, Mamoru</name>
      </author>
      <author>
        <name>Mori, Masaki</name>
      </author>
      <author>
        <name>Doki, Yuichiro</name>
      </author>
      <author>
        <name>Eguchi, Hidetoshi</name>
      </author>
      <author>
        <name>Oshima, Masanobu</name>
      </author>
      <author>
        <name>Suzuki, Yutaka</name>
      </author>
      <author>
        <name>Shibata, Tatsuhiro</name>
      </author>
      <author>
        <name>Mimori, Koshi</name>
      </author>
    </item>
    <item>
      <title>Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2</title>
      <link>https://escholarship.org/uc/item/8w61j7q2</link>
      <description>Squamous cell carcinoma of the external auditory canal (EACSCC) is an extraordinarily rare and aggressive malignant disease. Establishment of EACSCC cell line with robust molecular characteristics is essential for the basic and translational research of EACSCC. Here, we show the newly established EACSCC cell line SCEACono2, derived from a patient with well-to-moderately differentiated EACSCC. We analyzed histologic and genetic features of SCEACono2 hiring multiple experiments, including next-generation sequencing (NGS). Immunocytochemical staining of SCEACono2 showed positivity of p53 and SCC1/2. Furthermore, SCEACono2 exhibited a unique characteristic that cytokeratin, vimentin as well as cancer stem cell markers (CD44, CD133, ALP and Oct3/4) were positive. SCEACono2 had an ability to form tumors at the temporal lesion xenograft nude mice model. NGS revealed that SCEACono2 harbored the somatic mutations of TP53 (p.G245S) and NOTCH1 (p.A465T). RNA-seq and downstream bioinformatics...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8w61j7q2</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Komune, Noritaka</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Ono, Mayumi</name>
      </author>
      <author>
        <name>Imaizumi, Akira</name>
      </author>
      <author>
        <name>Masuda, Shogo</name>
      </author>
      <author>
        <name>Itoyama, Shinsaku</name>
      </author>
      <author>
        <name>Manako, Tomomi</name>
      </author>
      <author>
        <name>Kuga, Ryosuke</name>
      </author>
      <author>
        <name>Hongo, Takahiro</name>
      </author>
      <author>
        <name>Kogo, Ryunosuke</name>
      </author>
      <author>
        <name>Onishi, Hideya</name>
      </author>
      <author>
        <name>Nakagawa, Takashi</name>
      </author>
    </item>
    <item>
      <title>Impact of Positive-Margin Resection of External Auditory Canal Squamous Cell Carcinoma</title>
      <link>https://escholarship.org/uc/item/5wq1t1wq</link>
      <description>BACKGROUND: Positive-margin resection of external auditory canal squamous cell carcinoma (EAC-SCC) is still a major cause of recurrence. The aim of this study is to examine the clinical impact of positive-margin resection of EAC-SCCs.
METHODS: We retrospectively reviewed 40 surgical cases with en bloc temporal bone resection of EAC-SCC at a tertiary referral center from October 2016 to March 2022.
RESULTS: Two-year disease-specific, overall, and disease-free survival rates for all 40 cases reviewed were 85.2%, 88.85%, and 76.96%, respectively. En bloc resection with a negative margin significantly improved patient prognosis (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Positive-margin resection was observed in 9/40 cases (22.5%). Insufficient assessment of preoperative images was the cause in two of these cases. Postoperative lymph node metastasis and distant metastasis were observed in cases in which vascular, lymphatic duct or perineural invasion was found on postoperative pathological examination....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5wq1t1wq</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Komune, Noritaka</name>
      </author>
      <author>
        <name>Kuga, Ryosuke</name>
      </author>
      <author>
        <name>Hongo, Takahiro</name>
      </author>
      <author>
        <name>Kuga, Daisuke</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Nakagawa, Takashi</name>
      </author>
    </item>
    <item>
      <title>Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma</title>
      <link>https://escholarship.org/uc/item/42t0m9jk</link>
      <description>BackgroundDriver alterations may represent novel candidates for driver gene-guided therapy; however, intrahepatic cholangiocarcinoma (ICC) with multiple genomic aberrations makes them intractable. Therefore, the pathogenesis and metabolic changes of ICC need to be understood to develop new treatment strategies. We aimed to unravel the evolution of ICC and identify ICC-specific metabolic characteristics to investigate the metabolic pathway associated with ICC development using multiregional sampling to encompass the intra- and inter-tumoral heterogeneity.MethodsWe performed the genomic, transcriptomic, proteomic and metabolomic analysis of 39–77 ICC tumour samples and eleven normal samples. Further, we analysed their cell proliferation and viability.ResultsWe demonstrated that intra-tumoral heterogeneity of ICCs with distinct driver genes per case exhibited neutral evolution, regardless of their tumour stage. Upregulation of BCAT1 and BCAT2 indicated the involvement of ‘Val Leu...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/42t0m9jk</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Kitagawa, Akihiro</name>
      </author>
      <author>
        <name>Osawa, Tsuyoshi</name>
      </author>
      <author>
        <name>Noda, Miwa</name>
      </author>
      <author>
        <name>Kobayashi, Yuta</name>
      </author>
      <author>
        <name>Aki, Sho</name>
      </author>
      <author>
        <name>Nakano, Yusuke</name>
      </author>
      <author>
        <name>Saito, Tomoko</name>
      </author>
      <author>
        <name>Shimizu, Dai</name>
      </author>
      <author>
        <name>Komatsu, Hisateru</name>
      </author>
      <author>
        <name>Sugaya, Maki</name>
      </author>
      <author>
        <name>Takahashi, Junichi</name>
      </author>
      <author>
        <name>Kosai, Keisuke</name>
      </author>
      <author>
        <name>Takao, Seiichiro</name>
      </author>
      <author>
        <name>Motomura, Yushi</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Hu, Qingjiang</name>
      </author>
      <author>
        <name>Fujii, Atsushi</name>
      </author>
      <author>
        <name>Wakiyama, Hiroaki</name>
      </author>
      <author>
        <name>Tobo, Taro</name>
      </author>
      <author>
        <name>Uchida, Hiroki</name>
      </author>
      <author>
        <name>Sugimachi, Keishi</name>
      </author>
      <author>
        <name>Shibata, Kohei</name>
      </author>
      <author>
        <name>Utsunomiya, Tohru</name>
      </author>
      <author>
        <name>Kobayashi, Shogo</name>
      </author>
      <author>
        <name>Ishii, Hideshi</name>
      </author>
      <author>
        <name>Hasegawa, Takanori</name>
      </author>
      <author>
        <name>Masuda, Takaaki</name>
      </author>
      <author>
        <name>Matsui, Yusuke</name>
      </author>
      <author>
        <name>Niida, Atsushi</name>
      </author>
      <author>
        <name>Soga, Tomoyoshi</name>
      </author>
      <author>
        <name>Suzuki, Yutaka</name>
      </author>
      <author>
        <name>Miyano, Satoru</name>
      </author>
      <author>
        <name>Aburatani, Hiroyuki</name>
      </author>
      <author>
        <name>Doki, Yuichiro</name>
      </author>
      <author>
        <name>Eguchi, Hidetoshi</name>
      </author>
      <author>
        <name>Mori, Masaki</name>
      </author>
      <author>
        <name>Nakayama, Keiichi I</name>
      </author>
      <author>
        <name>Shimamura, Teppei</name>
      </author>
      <author>
        <name>Shibata, Tatsuhiro</name>
      </author>
      <author>
        <name>Mimori, Koshi</name>
      </author>
    </item>
    <item>
      <title>Novel eicosanoid signature in plasma provides diagnostic for metabolic dysfunction-associated steatotic liver disease</title>
      <link>https://escholarship.org/uc/item/7kn26696</link>
      <description>There is a clinical need for a simple test implementable at the primary point of care to identify individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) in the population. Blood plasma samples from adult patients with varying phenotypes of MASLD were used to identify a minimal set of lipid analytes reflective of underlying histologically confirmed MASLD. Samples were obtained from the NIDDK Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) NAFLD Database prospective cohort study (MASLD group; N&amp;nbsp;=&amp;nbsp;301). Samples of control subjects were obtained from cohort studies at the University of California San Diego (control group; N&amp;nbsp;=&amp;nbsp;48). Plasma samples were utilized for targeted quantitation of circulating eicosanoids, related bioactive metabolites, and polyunsaturated fatty acids by ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) lipidomics analysis. Bioinformatic approaches were used to discover a...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7kn26696</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Quehenberger, Oswald</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>Armando, Aaron M</name>
      </author>
      <author>
        <name>Cedeno, Tiffany H</name>
      </author>
      <author>
        <name>Loomba, Rohit</name>
        <uri>https://orcid.org/0000-0002-4845-9991</uri>
      </author>
      <author>
        <name>Sanyal, Arun J</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
    </item>
    <item>
      <title>Fluorescent biosensor imaging meets deterministic mathematical modelling: quantitative investigation of signalling compartmentalization</title>
      <link>https://escholarship.org/uc/item/1kv0404b</link>
      <description>Cells execute specific responses to diverse environmental cues by encoding information in distinctly compartmentalized biochemical signalling reactions. Genetically encoded fluorescent biosensors enable the spatial and temporal monitoring of signalling events in live cells. Temporal and spatiotemporal computational models can be used to interpret biosensor experiments in complex biochemical networks and to explore hypotheses that are difficult to test experimentally. In this review, we first provide brief discussions of the experimental toolkit of fluorescent biosensors as well as computational basics with a focus on temporal and spatiotemporal deterministic models. We then describe how we used this combined approach to identify and investigate a protein kinase A (PKA) - cAMP - Ca&lt;sup&gt;2+&lt;/sup&gt; oscillatory circuit in MIN6 β cells, a mouse pancreatic β cell system. We describe the application of this combined approach to interrogate how this oscillatory circuit is differentially...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1kv0404b</guid>
      <pubDate>Fri, 8 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Posner, Clara</name>
      </author>
      <author>
        <name>Mehta, Sohum</name>
        <uri>https://orcid.org/0000-0003-4764-8579</uri>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
    </item>
    <item>
      <title>Pericytes Enrich the Basement Membrane and Reduce Neutrophil Transmigration in an In Vitro Model of Peripheral Inflammation at the Blood–Brain Barrier</title>
      <link>https://escholarship.org/uc/item/55p1s5p1</link>
      <description>Sepsis is the most lethal and expensive condition treated in intensive care units. Sepsis survivors frequently suffer long-term cognitive impairment, which has been linked to the breakdown of the blood-brain barrier (BBB) during a sepsis-associated "cytokine storm". Because animal models poorly recapitulate sepsis pathophysiology, human models are needed to understand sepsis-associated brain injury and to develop novel therapeutic strategies. With the concurrent emergence of tissue chip technologies and the maturation of protocols for human induced pluripotent stem cell (hiPSC), we can now develop advanced in&amp;nbsp;vitro models of the human BBB and immune system to understand the relationship between systemic inflammation and brain injury. Here, we present a BBB model of the primary barrier developed on the μSiM (microphysiological system enabled by an ultrathin silicon nanomembrane) tissue chip platform. The model features isogenically matched hiPSC-derived extended endothelial...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/55p1s5p1</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>McCloskey, Molly C</name>
      </author>
      <author>
        <name>Ahmad, S Danial</name>
      </author>
      <author>
        <name>Widom, Louis P</name>
      </author>
      <author>
        <name>Kasap, Pelin</name>
      </author>
      <author>
        <name>Gastfriend, Benjamin D</name>
        <uri>https://orcid.org/0000-0002-4677-1455</uri>
      </author>
      <author>
        <name>Shusta, Eric V</name>
      </author>
      <author>
        <name>Palecek, Sean P</name>
      </author>
      <author>
        <name>Engelhardt, Britta</name>
      </author>
      <author>
        <name>Gaborski, Thomas R</name>
      </author>
      <author>
        <name>Flax, Jonathan</name>
      </author>
      <author>
        <name>Waugh, Richard E</name>
      </author>
      <author>
        <name>McGrath, James L</name>
      </author>
    </item>
    <item>
      <title>Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein–Protein Interaction Inhibitors</title>
      <link>https://escholarship.org/uc/item/0f31h0p2</link>
      <description>The covalent reversible modification of proteins is a validated strategy for the development of probes and candidate therapeutics. However, the covalent reversible targeting of noncatalytic lysines is particularly challenging. Herein, we characterize the 2-hydroxy-1-naphthaldehyde (HNA) fragment as a targeted covalent reversible ligand of a noncatalytic lysine (Lys&lt;sup&gt;720&lt;/sup&gt;) of the Krev interaction trapped 1 (KRIT1) protein. We show that the interaction of HNA with KRIT1 is highly specific, results in prolonged residence time of &amp;gt;8 h, and inhibits the Heart of glass 1 (HEG1)-KRIT1 protein-protein interaction (PPI). Screening of HNA derivatives identified analogs exhibiting similar binding modes as the parent fragment but faster target engagement and stronger inhibition activity. These results demonstrate that HNA is an efficient site-directing fragment with promise in developing HEG1-KRIT1 PPI inhibitors. Further, the aldimine chemistry, when coupled with templating effects...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f31h0p2</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Francisco, Karol R</name>
      </author>
      <author>
        <name>Bruystens, Jessica</name>
      </author>
      <author>
        <name>Varricchio, Carmine</name>
      </author>
      <author>
        <name>McCurdy, Sara</name>
      </author>
      <author>
        <name>Wu, Jian</name>
        <uri>https://orcid.org/0000-0002-8031-9462</uri>
      </author>
      <author>
        <name>Lopez-Ramirez, Miguel A</name>
      </author>
      <author>
        <name>Ginsberg, Mark</name>
      </author>
      <author>
        <name>Caffrey, Conor R</name>
      </author>
      <author>
        <name>Brancale, Andrea</name>
      </author>
      <author>
        <name>Gingras, Alexandre R</name>
      </author>
      <author>
        <name>Hixon, Mark S</name>
      </author>
      <author>
        <name>Ballatore, Carlo</name>
        <uri>https://orcid.org/0000-0002-2718-3850</uri>
      </author>
    </item>
    <item>
      <title>Dural mural cells paint an anti-inflammatory picture</title>
      <link>https://escholarship.org/uc/item/7651h10c</link>
      <description>Mural cells directly contact macrophages in the dural layer of the meninges to suppress pro-inflammatory phenotypes, including antigen presentation and lymphocyte differentiation. These mechanisms represent new targets for modulating CNS immune surveillance and pathological inflammation (Min et al. 2024. J. Exp. Med.https://doi.org/10.1084/jem.20230326).</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7651h10c</guid>
      <pubDate>Fri, 25 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lummis, Nicole C</name>
      </author>
      <author>
        <name>Gastfriend, Benjamin D</name>
        <uri>https://orcid.org/0000-0002-4677-1455</uri>
      </author>
      <author>
        <name>Daneman, Richard</name>
      </author>
    </item>
    <item>
      <title>Notch3 directs differentiation of brain mural cells from human pluripotent stem cell–derived neural crest</title>
      <link>https://escholarship.org/uc/item/41x9r57k</link>
      <description>Brain mural cells regulate development and function of the blood-brain barrier and control blood flow. Existing in vitro models of human brain mural cells have low expression of key mural cell genes, including &lt;i&gt;NOTCH3&lt;/i&gt;. Thus, we asked whether activation of Notch3 signaling in hPSC-derived neural crest could direct the differentiation of brain mural cells with an improved transcriptional profile. Overexpression of the Notch3 intracellular domain (N3ICD) induced expression of mural cell markers PDGFRβ, TBX2, &lt;i&gt;FOXS1&lt;/i&gt;, &lt;i&gt;KCNJ8&lt;/i&gt;, &lt;i&gt;SLC6A12&lt;/i&gt;, and endogenous Notch3. The resulting N3ICD-derived brain mural cells produced extracellular matrix, self-assembled with endothelial cells, and had functional K&lt;sub&gt;ATP&lt;/sub&gt; channels. ChIP-seq revealed that Notch3 serves as a direct input to relatively few genes in the context of this differentiation process. Our work demonstrates that activation of Notch3 signaling is sufficient to direct the differentiation of neural crest to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/41x9r57k</guid>
      <pubDate>Fri, 25 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gastfriend, Benjamin D</name>
        <uri>https://orcid.org/0000-0002-4677-1455</uri>
      </author>
      <author>
        <name>Snyder, Margaret E</name>
      </author>
      <author>
        <name>Holt, Hope E</name>
      </author>
      <author>
        <name>Daneman, Richard</name>
      </author>
      <author>
        <name>Palecek, Sean P</name>
      </author>
      <author>
        <name>Shusta, Eric V</name>
      </author>
    </item>
    <item>
      <title>Structural analyses of the PKA RIIβ holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma</title>
      <link>https://escholarship.org/uc/item/754321r8</link>
      <description>When the J-domain of the heat shock protein DnaJB1 is fused to the catalytic (C) subunit of cAMP-dependent protein kinase (PKA), replacing exon 1, this fusion protein, J-C subunit (J-C), becomes the driver of fibrolamellar hepatocellular carcinoma (FL-HCC). Here, we use cryo-electron microscopy (cryo-EM) to characterize J-C bound to RIIβ, the major PKA regulatory (R) subunit in liver, thus reporting the first cryo-EM structure of any PKA holoenzyme. We report several differences in both structure and dynamics that could not be captured by the conventional crystallography approaches used to obtain prior structures. Most striking is the asymmetry caused by the absence of the second cyclic nucleotide binding (CNB) domain and the J-domain in one of the RIIβ:J-C protomers. Using molecular dynamics (MD) simulations, we discovered that this asymmetry is already present in the wild-type (WT) RIIβ2C2 but had been masked in the previous crystal structure. This asymmetry may link to the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/754321r8</guid>
      <pubDate>Wed, 2 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lu, Tsan-Wen</name>
      </author>
      <author>
        <name>Aoto, Phillip C</name>
      </author>
      <author>
        <name>Weng, Jui-Hung</name>
      </author>
      <author>
        <name>Nielsen, Cole</name>
      </author>
      <author>
        <name>Cash, Jennifer N</name>
        <uri>https://orcid.org/0000-0002-0277-7652</uri>
      </author>
      <author>
        <name>Hall, James</name>
        <uri>https://orcid.org/0000-0002-9843-7520</uri>
      </author>
      <author>
        <name>Zhang, Ping</name>
      </author>
      <author>
        <name>Simon, Sanford M</name>
      </author>
      <author>
        <name>Cianfrocco, Michael A</name>
      </author>
      <author>
        <name>Taylor, Susan S</name>
      </author>
    </item>
    <item>
      <title>Interface Engineering of Carrier-Protein-Dependent Metabolic Pathways</title>
      <link>https://escholarship.org/uc/item/7m93c0nt</link>
      <description>Carrier-protein-dependent metabolic pathways biosynthesize fatty acids, polyketides, and non-ribosomal peptides, producing metabolites with important pharmaceutical, environmental, and industrial properties. Recent findings demonstrate that these pathways rely on selective communication mechanisms involving protein-protein interactions (PPIs) that guide enzyme reactivity and timing. While rational design of these PPIs could enable pathway design and modification, this goal remains a challenge due to the complex nature of protein interfaces. Computational methods offer an encouraging avenue, though many score functions fail to predict experimental observables, leading to low success rates. Here, we improve upon the Rosetta score function, leveraging experimental data through iterative rounds of computational prediction and mutagenesis, to design a hybrid fatty acid-non-ribosomal peptide initiation pathway. By increasing the weight of the electrostatic score term, the computational...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7m93c0nt</guid>
      <pubDate>Mon, 30 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sztain, Terra</name>
      </author>
      <author>
        <name>Corpuz, Joshua C</name>
      </author>
      <author>
        <name>Bartholow, Thomas G</name>
      </author>
      <author>
        <name>Hernandez, Javier O Sanlley</name>
      </author>
      <author>
        <name>Jiang, Ziran</name>
      </author>
      <author>
        <name>Mellor, Desirae A</name>
      </author>
      <author>
        <name>Heberlig, Graham W</name>
      </author>
      <author>
        <name>La Clair, James J</name>
        <uri>https://orcid.org/0000-0001-6500-4107</uri>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
      <author>
        <name>Burkart, Michael D</name>
        <uri>https://orcid.org/0000-0002-4472-2254</uri>
      </author>
    </item>
    <item>
      <title>Light-gated integrator for highlighting kinase activity in living cells</title>
      <link>https://escholarship.org/uc/item/3862836p</link>
      <description>Protein kinases are key signaling nodes that regulate fundamental biological and disease processes. Illuminating kinase signaling from multiple angles can provide deeper insights into disease mechanisms and improve therapeutic targeting. While fluorescent biosensors are powerful tools for visualizing live-cell kinase activity dynamics in real time, new molecular tools are needed that enable recording of transient signaling activities for post hoc analysis and targeted manipulation. Here, we develop a light-gated kinase activity coupled transcriptional integrator (KINACT) that converts dynamic kinase signals into “permanent” fluorescent marks. KINACT enables robust monitoring of kinase activity across scales, accurately recording subcellular PKA activity, highlighting PKA activity distribution in 3D cultures, and identifying PKA activators and inhibitors in high-throughput screens. We further leverage the ability of KINACT to drive signaling effector expression to allow feedback...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3862836p</guid>
      <pubDate>Tue, 24 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lin, Wei</name>
      </author>
      <author>
        <name>Phatarphekar, Abhishek</name>
      </author>
      <author>
        <name>Zhong, Yanghao</name>
      </author>
      <author>
        <name>Liu, Longwei</name>
      </author>
      <author>
        <name>Kwon, Hyung-Bae</name>
      </author>
      <author>
        <name>Gerwick, William H</name>
        <uri>https://orcid.org/0000-0003-1403-4458</uri>
      </author>
      <author>
        <name>Wang, Yingxiao</name>
      </author>
      <author>
        <name>Mehta, Sohum</name>
        <uri>https://orcid.org/0000-0003-4764-8579</uri>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
    </item>
    <item>
      <title>Re-examining the role of the dorsal fan-shaped body in promoting sleep in Drosophila</title>
      <link>https://escholarship.org/uc/item/356745vb</link>
      <description>The needs fulfilled by sleep are unknown, though the effects of insufficient sleep are manifold. To better understand how the need to sleep is sensed and discharged, much effort has gone into identifying the neural circuits involved in regulating arousal, especially those that promote sleep. In prevailing models, the dorsal fan-shaped body (dFB) plays a central role in this process in the fly brain. In the present study we manipulated various properties of the dFB including its electrical activity, synaptic output, and endogenous gene expression. In each of these experimental contexts we were unable to identify any effect on sleep that could be unambiguously mapped to the dFB. Furthermore, we found evidence that sleep phenotypes previously attributed to the dFB were caused by genetic manipulations that inadvertently targeted the ventral nerve cord. We also examined expression of two genes whose purported effects have been attributed to functions within a specific subpopulation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/356745vb</guid>
      <pubDate>Tue, 24 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>De, Joydeep</name>
      </author>
      <author>
        <name>Wu, Meilin</name>
      </author>
      <author>
        <name>Lambatan, Vanessa</name>
      </author>
      <author>
        <name>Hua, Yue</name>
      </author>
      <author>
        <name>Joiner, William J</name>
      </author>
    </item>
    <item>
      <title>Fatty Acids and Their Lipogenic Enzymes in Anorexia Nervosa Clinical Subtypes</title>
      <link>https://escholarship.org/uc/item/4jv309pk</link>
      <description>Disordered eating behavior differs between the restricting subtype (AN-R) and the binging and purging subtype (AN-BP) of anorexia nervosa (AN). Yet, little is known about how these differences impact fatty acid (FA) dysregulation in AN. To address this question, we analyzed 26 FAs and 7 FA lipogenic enzymes (4 desaturases and 3 elongases) in 96 women: 25 AN-R, 25 AN-BP, and 46 healthy control women. Our goal was to assess subtype-specific patterns. Lauric acid was significantly higher in AN-BP than in AN-R at the fasting timepoint (&lt;i&gt;p&lt;/i&gt; = 0.038) and displayed significantly different postprandial changes 2 h after eating. AN-R displayed significantly higher levels of n-3 alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid, and n-6 linoleic acid and gamma-linolenic acid compared to controls. AN-BP showed elevated EPA and saturated lauric acid compared to controls. Higher EPA was associated with elevated anxiety in AN-R (&lt;i&gt;p&lt;/i&gt; = 0.035)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4jv309pk</guid>
      <pubDate>Wed, 4 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Nguyen, Nhien</name>
      </author>
      <author>
        <name>Woodside, D Blake</name>
      </author>
      <author>
        <name>Lam, Eileen</name>
      </author>
      <author>
        <name>Quehenberger, Oswald</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>German, J Bruce</name>
        <uri>https://orcid.org/0000-0002-4856-7693</uri>
      </author>
      <author>
        <name>Shih, Pei-an Betty</name>
      </author>
    </item>
    <item>
      <title>Structural and dynamic changes in P-Rex1 upon activation by PIP3 and inhibition by IP4</title>
      <link>https://escholarship.org/uc/item/8k46365q</link>
      <description>PIP&lt;sub&gt;3&lt;/sub&gt;-dependent Rac exchanger 1 (P-Rex1) is abundantly expressed in neutrophils and plays central roles in chemotaxis and cancer metastasis by serving as a guanine-nucleotide exchange factor (GEF) for Rac. The enzyme is synergistically activated by PIP&lt;sub&gt;3&lt;/sub&gt; and heterotrimeric Gβγ subunits, but mechanistic details remain poorly understood. While investigating the regulation of P-Rex1 by PIP&lt;sub&gt;3&lt;/sub&gt;, we discovered that Ins(1,3,4,5)P&lt;sub&gt;4&lt;/sub&gt; (IP&lt;sub&gt;4&lt;/sub&gt;) inhibits P-Rex1 activity and induces large decreases in backbone dynamics in diverse regions of the protein. Cryo-electron microscopy analysis of the P-Rex1·IP&lt;sub&gt;4&lt;/sub&gt; complex revealed a conformation wherein the pleckstrin homology (PH) domain occludes the active site of the Dbl homology (DH) domain. This configuration is stabilized by interactions between the first DEP domain (DEP1) and the DH domain and between the PH domain and a 4-helix bundle (4HB) subdomain that extends from the C-terminal domain...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8k46365q</guid>
      <pubDate>Thu, 29 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ravala, Sandeep K</name>
      </author>
      <author>
        <name>Adame-Garcia, Sendi Rafael</name>
      </author>
      <author>
        <name>Li, Sheng</name>
      </author>
      <author>
        <name>Chen, Chun-Liang</name>
      </author>
      <author>
        <name>Cianfrocco, Michael A</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Cash, Jennifer N</name>
        <uri>https://orcid.org/0000-0002-0277-7652</uri>
      </author>
      <author>
        <name>Tesmer, John JG</name>
      </author>
    </item>
    <item>
      <title>ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis</title>
      <link>https://escholarship.org/uc/item/9g90f6cs</link>
      <description>BACKGROUND &amp;amp; AIMS: Hepatocellular carcinoma (HCC), a leading cause of cancer-related death, is associated with viral hepatitis, non-alcoholic steatohepatitis (NASH), and alcohol-related steatohepatitis, all of which trigger endoplasmic reticulum (ER) stress, hepatocyte death, inflammation, and compensatory proliferation. Using ER stress-prone MUP-uPA mice, we established that ER stress and hypernutrition cooperate to cause NASH and HCC, but the contribution of individual stress effectors, such as activating transcription factor 4 (ATF4), to HCC and their underlying mechanisms of action remained unknown.
METHODS: Hepatocyte-specific ATF4-deficient MUP-uPA mice (MUP-uPA/Atf4&lt;sup&gt;Δhep&lt;/sup&gt;) and control MUP-uPA/Atf4&lt;sup&gt;F/F&lt;/sup&gt; mice were fed a high-fat diet to induce NASH-related HCC, and Atf4&lt;sup&gt;F/F&lt;/sup&gt; and Atf4&lt;sup&gt;Δhep&lt;/sup&gt; mice were injected with diethylnitrosamine to model carcinogen-induced HCC. Histological, biochemical, and RNA-sequencing analyses were performed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9g90f6cs</guid>
      <pubDate>Tue, 27 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>He, Feng</name>
      </author>
      <author>
        <name>Zhang, Peng</name>
        <uri>https://orcid.org/0000-0003-0469-7151</uri>
      </author>
      <author>
        <name>Liu, Junlai</name>
      </author>
      <author>
        <name>Wang, Ruolei</name>
      </author>
      <author>
        <name>Kaufman, Randal J</name>
      </author>
      <author>
        <name>Yaden, Benjamin C</name>
      </author>
      <author>
        <name>Karin, Michael</name>
      </author>
    </item>
    <item>
      <title>Multiscale computational modeling of the effects of 2’-deoxy-ATP on cardiac muscle calcium handling</title>
      <link>https://escholarship.org/uc/item/5938s83r</link>
      <description>2'-Deoxy-ATP (dATP), a naturally occurring near analog of ATP, is a well-documented myosin activator that has been shown to increase contractile force, improve pump function, and enhance lusitropy in the heart. Calcium transients in cardiomyocytes with elevated levels of dATP show faster calcium decay compared with cardiomyocytes with basal levels of dATP, but the mechanisms behind this are unknown. Here, we design and utilize a multiscale computational modeling framework to test the hypothesis that dATP acts on the sarcoendoplasmic reticulum calcium-ATPase (SERCA) pump to accelerate calcium re-uptake into the sarcoplasmic reticulum during cardiac relaxation. Gaussian accelerated molecular dynamics simulations of human cardiac SERCA2A in the E1 &lt;i&gt;apo&lt;/i&gt;, ATP-bound and dATP-bound states showed that dATP forms more stable contacts in the nucleotide binding pocket of SERCA and leads to increased closure of cytosolic domains. These structural changes ultimately lead to changes in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5938s83r</guid>
      <pubDate>Tue, 27 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hock, Marcus T</name>
      </author>
      <author>
        <name>Teitgen, Abigail E</name>
      </author>
      <author>
        <name>McCabe, Kimberly J</name>
      </author>
      <author>
        <name>Hirakis, Sophia P</name>
      </author>
      <author>
        <name>Huber, Gary A</name>
      </author>
      <author>
        <name>Regnier, Michael</name>
      </author>
      <author>
        <name>Amaro, Rommie E</name>
        <uri>https://orcid.org/0000-0002-9275-9553</uri>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
      <author>
        <name>McCulloch, Andrew D</name>
        <uri>https://orcid.org/0000-0002-1708-5675</uri>
      </author>
    </item>
    <item>
      <title>Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release</title>
      <link>https://escholarship.org/uc/item/9j97n3xr</link>
      <description>Inherited mutations in human beta-cardiac myosin (M2β) can lead to severe forms of heart failure. The E525K mutation in M2β is associated with dilated cardiomyopathy (DCM) and was found to stabilize the interacting heads motif (IHM) and autoinhibited super-relaxed (SRX) state in dimeric heavy meromyosin. However, in monomeric M2β subfragment 1 (S1) we found that E525K enhances (threefold) the maximum steady-state actin-activated ATPase activity (&lt;i&gt;k&lt;/i&gt; &lt;sub&gt;cat&lt;/sub&gt;) and decreases (eightfold) the actin concentration at which ATPase is one-half maximal (&lt;i&gt;K&lt;/i&gt; &lt;sub&gt;ATPase&lt;/sub&gt;). We also found a twofold to fourfold increase in the actin-activated power stroke and phosphate release rate constants at 30 μM actin, which overall enhanced the duty ratio threefold. Loaded motility assays revealed that the enhanced intrinsic motor activity translates to increased ensemble force in M2β S1. Glutamate 525, located near the actin binding region in the so-called activation loop, is highly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9j97n3xr</guid>
      <pubDate>Thu, 22 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bodt, Skylar ML</name>
      </author>
      <author>
        <name>Ge, Jinghua</name>
      </author>
      <author>
        <name>Ma, Wen</name>
      </author>
      <author>
        <name>Rasicci, David V</name>
      </author>
      <author>
        <name>Desetty, Rohini</name>
      </author>
      <author>
        <name>McCammon, J Andrew</name>
        <uri>https://orcid.org/0000-0003-3065-1456</uri>
      </author>
      <author>
        <name>Yengo, Christopher M</name>
      </author>
    </item>
    <item>
      <title>The landscape of cancer-rewired GPCR signaling axes</title>
      <link>https://escholarship.org/uc/item/4r71t7xg</link>
      <description>We explored the dysregulation of G-protein-coupled receptor (GPCR) ligand systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands and their biosynthetic enzymes. Multiple GPCRs are differentially regulated together with their upstream partners across cancer subtypes and are associated to specific transcriptional programs and to patient survival patterns. The expression of both receptor-ligand (or enzymes) partners improved patient stratification, suggesting a synergistic role for the activation of GPCR networks in modulating cancer phenotypes. Remarkably, we identified many such axes across several cancer molecular subtypes, including many involving receptor-biosynthetic enzymes for neurotransmitters. We found that GPCRs from these actionable axes, including, e.g., muscarinic, adenosine, 5-hydroxytryptamine, and chemokine receptors, are the targets of multiple drugs displaying...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4r71t7xg</guid>
      <pubDate>Sat, 3 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Arora, Chakit</name>
      </author>
      <author>
        <name>Matic, Marin</name>
      </author>
      <author>
        <name>Bisceglia, Luisa</name>
      </author>
      <author>
        <name>Di Chiaro, Pierluigi</name>
      </author>
      <author>
        <name>De Oliveira Rosa, Natalia</name>
      </author>
      <author>
        <name>Carli, Francesco</name>
      </author>
      <author>
        <name>Clubb, Lauren</name>
      </author>
      <author>
        <name>Nemati Fard, Lorenzo Amir</name>
      </author>
      <author>
        <name>Kargas, Giorgos</name>
      </author>
      <author>
        <name>Diaferia, Giuseppe R</name>
      </author>
      <author>
        <name>Vukotic, Ranka</name>
      </author>
      <author>
        <name>Licata, Luana</name>
      </author>
      <author>
        <name>Wu, Guanming</name>
      </author>
      <author>
        <name>Natoli, Gioacchino</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Raimondi, Francesco</name>
      </author>
    </item>
    <item>
      <title>A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC</title>
      <link>https://escholarship.org/uc/item/4d31m9qc</link>
      <description>The comprehensive genomic analysis of the head and neck squamous cell carcinoma (HNSCC) oncogenome revealed the frequent loss of p16INK4A (CDKN2A) and amplification of cyclin D1 genes in most human papillomavirus-negative HNSCC lesions. However, cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have shown modest effects in the clinic. The aberrant activation of the PI3K/mTOR pathway is highly prevalent in HNSCC, and recent clinical trials have shown promising clinical efficacy of mTOR inhibitors (mTORi) in the neoadjuvant and adjuvant settings but not in patients with advanced HNSCC. By implementing a kinome-wide CRISPR/Cas9 screen, we identified cell-cycle inhibition as a synthetic lethal target for mTORis. A combination of mTORi and palbociclib, a CDK4/6-specific inhibitor, showed strong synergism in HNSCC-derived cells in vitro and in vivo. Remarkably, we found that an adaptive increase in cyclin E1 (CCNE1) expression upon palbociclib treatment underlies the rapid acquired...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4d31m9qc</guid>
      <pubDate>Sat, 3 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Goto, Yusuke</name>
      </author>
      <author>
        <name>Koshizuka, Keiichi</name>
      </author>
      <author>
        <name>Ando, Toshinori</name>
      </author>
      <author>
        <name>Izumi, Hiroki</name>
      </author>
      <author>
        <name>Wu, Xingyu</name>
      </author>
      <author>
        <name>Sato, Kuniaki</name>
        <uri>https://orcid.org/0000-0001-6014-1911</uri>
      </author>
      <author>
        <name>Ishikawa, Tomohiko</name>
      </author>
      <author>
        <name>Ford, Kyle</name>
      </author>
      <author>
        <name>Feng, Xiaodong</name>
      </author>
      <author>
        <name>Wang, Zhiyong</name>
      </author>
      <author>
        <name>Arang, Nadia</name>
      </author>
      <author>
        <name>Allevato, Michael M</name>
      </author>
      <author>
        <name>Kishore, Ayush</name>
      </author>
      <author>
        <name>Mali, Prashant</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
    </item>
    <item>
      <title>Lipidomics of phospholipase A2 reveals exquisite specificity in macrophages</title>
      <link>https://escholarship.org/uc/item/8xr7f1z7</link>
      <description>Phospholipase A&lt;sub&gt;2&lt;/sub&gt; (PLA&lt;sub&gt;2&lt;/sub&gt;) constitutes a superfamily of enzymes that hydrolyze phospholipids at their sn-2 fatty acyl position. Our laboratory has demonstrated that PLA&lt;sub&gt;2&lt;/sub&gt; enzymes regulate membrane remodeling and cell signaling by their specificity toward their phospholipid substrates at the molecular level. Recent in&amp;nbsp;vitro studies show that each type of PLA&lt;sub&gt;2&lt;/sub&gt;, including Group IVA cytosolic PLA&lt;sub&gt;2&lt;/sub&gt; (cPLA&lt;sub&gt;2&lt;/sub&gt;), Group V secreted PLA&lt;sub&gt;2&lt;/sub&gt; (sPLA&lt;sub&gt;2&lt;/sub&gt;), Group VIA calcium independent PLA&lt;sub&gt;2&lt;/sub&gt; (iPLA&lt;sub&gt;2&lt;/sub&gt;) and Group VIIA lipoprotein-associated PLA&lt;sub&gt;2&lt;/sub&gt;, also known as platelet-activating factor acetyl hydrolase, can discriminate exquisitely between fatty acids at the sn-2 position. Thus, these enzymes regulate the production of diverse PUFA precursors of inflammatory metabolites. We now determined PLA&lt;sub&gt;2&lt;/sub&gt; specificity in macrophage cells grown in cell culture, where the amounts and localization...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8xr7f1z7</guid>
      <pubDate>Mon, 29 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Murawska, Gosia M</name>
      </author>
      <author>
        <name>Armando, Aaron M</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
    </item>
    <item>
      <title>Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation</title>
      <link>https://escholarship.org/uc/item/7b734129</link>
      <description>Mathematical models of biochemical reaction networks are an important and emerging tool for the study of cell signaling networks involved in disease processes. One promising potential application of such mathematical models is the study of how disease-causing mutations promote the signaling phenotype that contributes to the disease. It is commonly assumed that one must have a thorough characterization of the network readily available for mathematical modeling to be useful, but we hypothesized that mathematical modeling could be useful when there is incomplete knowledge and that it could be a tool for discovery that opens new areas for further exploration. In the present study, we first develop a mechanistic mathematical model of a G-protein coupled receptor signaling network that is mutated in almost all cases of uveal melanoma and use model-driven explorations to uncover and explore multiple new areas for investigating this disease. Modeling the two major, mutually-exclusive,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7b734129</guid>
      <pubDate>Mon, 22 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Trogdon, Michael</name>
      </author>
      <author>
        <name>Abbott, Kodye</name>
      </author>
      <author>
        <name>Arang, Nadia</name>
      </author>
      <author>
        <name>Lande, Kathryn</name>
      </author>
      <author>
        <name>Kaur, Navneet</name>
      </author>
      <author>
        <name>Tong, Melinda</name>
      </author>
      <author>
        <name>Bakhoum, Mathieu</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Stites, Edward C</name>
      </author>
    </item>
    <item>
      <title>Mechanically induced topological transition of spectrin regulates its distribution in the mammalian cell cortex</title>
      <link>https://escholarship.org/uc/item/0kr0x3bm</link>
      <description>The cell cortex is a dynamic assembly formed by the plasma membrane and underlying cytoskeleton. As the main determinant of cell shape, the cortex ensures its integrity during passive and active deformations by adapting cytoskeleton topologies through yet poorly understood mechanisms. The spectrin meshwork ensures such adaptation in erythrocytes and neurons by adopting different organizations. Erythrocytes rely on triangular-like lattices of spectrin tetramers, whereas in neurons they are organized in parallel, periodic arrays. Since spectrin is ubiquitously expressed, we exploited Expansion Microscopy to discover that, in fibroblasts, distinct meshwork densities co-exist. Through biophysical measurements and computational modeling, we show that the non-polarized spectrin meshwork, with the intervention of actomyosin, can dynamically transition into polarized clusters fenced by actin stress fibers that resemble periodic arrays as found in neurons. Clusters experience lower mechanical...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kr0x3bm</guid>
      <pubDate>Sat, 20 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ghisleni, Andrea</name>
      </author>
      <author>
        <name>Bonilla-Quintana, Mayte</name>
      </author>
      <author>
        <name>Crestani, Michele</name>
      </author>
      <author>
        <name>Lavagnino, Zeno</name>
      </author>
      <author>
        <name>Galli, Camilla</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
      </author>
      <author>
        <name>Gauthier, Nils C</name>
      </author>
    </item>
    <item>
      <title>CTLA-4 blockade induces tumor pyroptosis via CD8+ T&amp;nbsp;cells in head and neck squamous cell carcinoma</title>
      <link>https://escholarship.org/uc/item/9p233441</link>
      <description>Immune checkpoint blockade (ICB) treatment has demonstrated excellent medical effects in oncology, and it is one of the most sought after immunotherapies for tumors. However, there are several issues with ICB therapy, including low response rates and a lack of effective efficacy predictors. Gasdermin-mediated pyroptosis is a typical inflammatory death mode. We discovered that increased expression of gasdermin protein was linked to a favorable tumor immune microenvironment and prognosis in head and neck squamous cell carcinoma (HNSCC). We used the mouse HNSCC cell lines 4MOSC1 (responsive to CTLA-4 blockade) and 4MOSC2 (resistant to CTLA-4 blockade) orthotopic models and demonstrated that CTLA-4 blockade treatment induced gasdermin-mediated pyroptosis of tumor cells, and gasdermin expression positively correlated to the effectiveness of CTLA-4 blockade treatment. We found that CTLA-4 blockade activated CD8&lt;sup&gt;+&lt;/sup&gt; T&amp;nbsp;cells and increased the levels of interferon γ (IFN-γ)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9p233441</guid>
      <pubDate>Tue, 16 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Shuo</name>
      </author>
      <author>
        <name>Wu, Zhi-Zhong</name>
      </author>
      <author>
        <name>Zhu, Su-Wen</name>
      </author>
      <author>
        <name>Wan, Shu-Cheng</name>
      </author>
      <author>
        <name>Zhang, Meng-Jie</name>
      </author>
      <author>
        <name>Zhang, Bo-Xin</name>
      </author>
      <author>
        <name>Yang, Qi-Chao</name>
      </author>
      <author>
        <name>Xiao, Yao</name>
      </author>
      <author>
        <name>Li, Hao</name>
      </author>
      <author>
        <name>Mao, Liang</name>
      </author>
      <author>
        <name>Wang, Zhi-Yong</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Sun, Zhi-Jun</name>
      </author>
    </item>
    <item>
      <title>Structural insights into GABAA receptor potentiation by Quaalude.</title>
      <link>https://escholarship.org/uc/item/7nd4h9bf</link>
      <description>Methaqualone, a quinazolinone marketed commercially as Quaalude, is a central nervous system depressant that was used clinically as a sedative-hypnotic, then became a notorious recreational drug in the 1960s-80s. Due to its high abuse potential, medical use of methaqualone was eventually prohibited, yet it persists as a globally abused substance. Methaqualone principally targets GABAA receptors, which are the major inhibitory neurotransmitter-gated ion channels in the brain. The restricted status and limited accessibility of methaqualone have contributed to its pharmacology being understudied. Here, we use cryo-EM to localize the GABAA receptor binding sites of methaqualone and its more potent derivative, PPTQ, to the same intersubunit transmembrane sites targeted by the general anesthetics propofol and etomidate. Both methaqualone and PPTQ insert more deeply into subunit interfaces than the previously-characterized modulators. Binding of quinazolinones to this site results in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7nd4h9bf</guid>
      <pubDate>Tue, 16 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chojnacka, Weronika</name>
      </author>
      <author>
        <name>Teng, Jinfeng</name>
      </author>
      <author>
        <name>Kim, Jeong</name>
      </author>
      <author>
        <name>Jensen, Anders</name>
      </author>
      <author>
        <name>Hibbs, Ryan</name>
      </author>
    </item>
    <item>
      <title>Bioluminescent Genetically Encoded Glutamate Indicators for Molecular Imaging of Neuronal Activity</title>
      <link>https://escholarship.org/uc/item/1pv93608</link>
      <description>Genetically encoded optical sensors and advancements in microscopy instrumentation and techniques have revolutionized the scientific toolbox available for probing complex biological processes such as release of specific neurotransmitters. Most genetically encoded optical sensors currently used are based on fluorescence and have been highly successful tools for single-cell imaging in superficial brain regions. However, there remains a need to develop new tools for reporting neuronal activity &lt;i&gt;in vivo&lt;/i&gt; within deeper structures without the need for hardware such as lenses or fibers to be implanted within the brain. Our approach to this problem is to replace the fluorescent elements of the existing biosensors with bioluminescent elements. This eliminates the need of external light sources to illuminate the sensor, thus allowing deeper brain regions to be imaged noninvasively. Here, we report the development of the first genetically encoded neurotransmitter indicators based on...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1pv93608</guid>
      <pubDate>Tue, 16 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Petersen, Eric D</name>
      </author>
      <author>
        <name>Lapan, Alexandra P</name>
      </author>
      <author>
        <name>Franco, E Alejandro Castellanos</name>
      </author>
      <author>
        <name>Fillion, Adam J</name>
      </author>
      <author>
        <name>Crespo, Emmanuel L</name>
      </author>
      <author>
        <name>Lambert, Gerard G</name>
      </author>
      <author>
        <name>Grady, Connor J</name>
      </author>
      <author>
        <name>Zanca, Albertina T</name>
      </author>
      <author>
        <name>Orcutt, Richard</name>
      </author>
      <author>
        <name>Hochgeschwender, Ute</name>
      </author>
      <author>
        <name>Shaner, Nathan C</name>
        <uri>https://orcid.org/0000-0002-0148-0769</uri>
      </author>
      <author>
        <name>Gilad, Assaf A</name>
      </author>
    </item>
    <item>
      <title>Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures</title>
      <link>https://escholarship.org/uc/item/5w46w360</link>
      <description>Schizophrenia (SZ) is a serious mental illness and neuropsychiatric brain disorder with behavioral symptoms that include hallucinations, delusions, disorganized behavior, and cognitive impairment. Regulation of such behaviors requires utilization of neurotransmitters released to mediate cell-cell communication which are essential to brain functions in health and disease. We hypothesized that SZ may involve dysregulation of neurotransmitters secreted from neurons. To gain an understanding of human SZ, induced neurons (iNs) were derived from SZ patients and healthy control subjects to investigate peptide neurotransmitters, known as neuropeptides, which represent the major class of transmitters. The iNs were subjected to depolarization by high KCl in the culture medium and the secreted neuropeptides were identified and quantitated by nano-LC-MS/MS tandem mass spectrometry. Several neuropeptides were identified from schizophrenia patient-derived neurons, including chromogranin B (CHGB),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5w46w360</guid>
      <pubDate>Sat, 6 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Podvin, Sonia</name>
      </author>
      <author>
        <name>Jones, Jeffrey</name>
      </author>
      <author>
        <name>Kang, Austin</name>
      </author>
      <author>
        <name>Goodman, Ryan</name>
      </author>
      <author>
        <name>Reed, Patrick</name>
      </author>
      <author>
        <name>Lietz, Christopher B</name>
      </author>
      <author>
        <name>Then, Joshua</name>
      </author>
      <author>
        <name>Lee, Kelly C</name>
        <uri>https://orcid.org/0000-0002-1674-4210</uri>
      </author>
      <author>
        <name>Eyler, Lisa T</name>
        <uri>https://orcid.org/0000-0002-7783-8798</uri>
      </author>
      <author>
        <name>Jeste, Dilip V</name>
      </author>
      <author>
        <name>Gage, Fred H</name>
      </author>
      <author>
        <name>Hook, Vivian</name>
      </author>
    </item>
    <item>
      <title>Paradigm shift required for translational research on the brain</title>
      <link>https://escholarship.org/uc/item/3wg3g21p</link>
      <description>Biomedical research on the brain has led to many discoveries and developments, such as understanding human consciousness and the mind and overcoming brain diseases. However, historical biomedical research on the brain has unique characteristics that differ from those of conventional biomedical research. For example, there are different scientific interpretations due to the high complexity of the brain and insufficient intercommunication between researchers of different disciplines owing to the limited conceptual and technical overlap of distinct backgrounds. Therefore, the development of biomedical research on the brain has been slower than that in other areas. Brain biomedical research has recently undergone a paradigm shift, and conducting patient-centered, large-scale brain biomedical research has become possible using emerging high-throughput analysis tools. Neuroimaging, multiomics, and artificial intelligence technology are the main drivers of this new approach, foreshadowing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3wg3g21p</guid>
      <pubDate>Mon, 17 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Yoon, Jong Hyuk</name>
      </author>
      <author>
        <name>Lee, Dongha</name>
      </author>
      <author>
        <name>Lee, Chany</name>
      </author>
      <author>
        <name>Cho, Eunji</name>
      </author>
      <author>
        <name>Lee, Seulah</name>
      </author>
      <author>
        <name>Cazenave-Gassiot, Amaury</name>
      </author>
      <author>
        <name>Kim, Kipom</name>
      </author>
      <author>
        <name>Chae, Sehyun</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
      <author>
        <name>Suh, Pann-Ghill</name>
      </author>
    </item>
    <item>
      <title>Network model of skeletal muscle cell signalling predicts differential responses to endurance and resistance exercise training</title>
      <link>https://escholarship.org/uc/item/6jk1j8wx</link>
      <description>Exercise-induced muscle adaptations vary based on exercise modality and intensity. We constructed a signalling network model from 87 published studies of human or rodent skeletal muscle cell responses to endurance or resistance exercise in vivo or simulated exercise in vitro. The network comprises 259 signalling interactions between 120 nodes, representing eight membrane receptors and eight canonical signalling pathways regulating 14 transcriptional regulators, 28 target genes and 12 exercise-induced phenotypes. Using this network, we formulated a logic-based ordinary differential equation model predicting time-dependent molecular and phenotypic alterations following acute endurance and resistance exercises. Compared with nine independent studies, the model accurately predicted 18/21 (85%) acute responses to resistance exercise and 12/16 (75%) acute responses to endurance exercise. Detailed sensitivity analysis of differential phenotypic responses to resistance and endurance training...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6jk1j8wx</guid>
      <pubDate>Fri, 7 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Fowler, Annabelle</name>
      </author>
      <author>
        <name>Knaus, Katherine R</name>
      </author>
      <author>
        <name>Khuu, Stephanie</name>
        <uri>https://orcid.org/0000-0003-2128-0358</uri>
      </author>
      <author>
        <name>Khalilimeybodi, Ali</name>
      </author>
      <author>
        <name>Schenk, Simon</name>
      </author>
      <author>
        <name>Ward, Samuel R</name>
      </author>
      <author>
        <name>Fry, Andrew C</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
        <uri>https://orcid.org/0000-0001-5953-4347</uri>
      </author>
      <author>
        <name>McCulloch, Andrew D</name>
        <uri>https://orcid.org/0000-0002-1708-5675</uri>
      </author>
    </item>
    <item>
      <title>Cholesterol-dependent LXR transcription factor activity represses pronociceptive effects of estrogen in sensory neurons and pain induced by myelin basic protein fragments</title>
      <link>https://escholarship.org/uc/item/2v9738w1</link>
      <description>Background: A bioactive myelin basic protein (MBP) fragment, comprising MBP&lt;sub&gt;84-104&lt;/sub&gt;, is released in sciatic nerve after chronic constriction injury (CCI). Intraneural injection (IN) of MBP&lt;sub&gt;84-104&lt;/sub&gt; in an intact sciatic nerve is sufficient to induce persistent neuropathic pain-like behavior via robust transcriptional remodeling at the injection site and ipsilateral dorsal root ganglia (DRG) and spinal cord. The sex (female)-specific pronociceptive activity of MBP&lt;sub&gt;84-104&lt;/sub&gt; associates with sex-specific changes in cholesterol metabolism and activation of estrogen receptor (ESR)1 signaling.
Methods: In male and female normal and post-CCI rat sciatic nerves, we assessed: (i) cholesterol precursor and metabolite levels by lipidomics; (ii) MBP&lt;sub&gt;84-104&lt;/sub&gt; interactors by mass spectrometry of MBP&lt;sub&gt;84-104&lt;/sub&gt; pull-down; and (iii) liver X receptor (LXR)α protein expression by immunoblotting. To test the effect of LXRα stimulation on IN MBP&lt;sub&gt;84-104&lt;/sub&gt;-induced...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2v9738w1</guid>
      <pubDate>Fri, 7 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hullugundi, Swathi K</name>
      </author>
      <author>
        <name>Dolkas, Jennifer</name>
      </author>
      <author>
        <name>Chernov, Andrei V</name>
      </author>
      <author>
        <name>Yaksh, Tony L</name>
      </author>
      <author>
        <name>Eddinger, Kelly A</name>
      </author>
      <author>
        <name>Angert, Mila</name>
      </author>
      <author>
        <name>Catroli, Glaucilene Ferreira</name>
      </author>
      <author>
        <name>Strongin, Alex Y</name>
      </author>
      <author>
        <name>Dougherty, Patrick M</name>
      </author>
      <author>
        <name>Li, Yan</name>
      </author>
      <author>
        <name>Quehenberger, Oswal</name>
        <uri>https://orcid.org/0000-0001-8950-9169</uri>
      </author>
      <author>
        <name>Armando, Aaron</name>
      </author>
      <author>
        <name>Shubayev, Veronica I</name>
      </author>
    </item>
    <item>
      <title>Toward a brighter constellation: multiorgan neuroimaging of neural and vascular dynamics in the spinal cord and brain</title>
      <link>https://escholarship.org/uc/item/0vr6h9s0</link>
      <description>Significance: Pain comprises a complex interaction between motor action and somatosensation that is dependent on dynamic interactions between the brain and spinal cord. This makes understanding pain particularly challenging as it involves rich interactions between many circuits (e.g., neural and vascular) and signaling cascades throughout the body. As such, experimentation on a single region may lead to an incomplete and potentially incorrect understanding of crucial underlying mechanisms.
Aim: We aimed to develop and validate tools to enable detailed and extended observation of neural and vascular activity in the brain and spinal cord. The first key set of innovations was targeted to developing novel imaging hardware that addresses the many challenges of multisite imaging. The second key set of innovations was targeted to enabling bioluminescent (BL) imaging, as this approach can address limitations of fluorescent microscopy including photobleaching, phototoxicity, and decreased...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0vr6h9s0</guid>
      <pubDate>Mon, 27 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Celinskis, Dmitrijs</name>
      </author>
      <author>
        <name>Black, Christopher J</name>
      </author>
      <author>
        <name>Murphy, Jeremy</name>
      </author>
      <author>
        <name>Barrios-Anderson, Adriel</name>
      </author>
      <author>
        <name>Friedman, Nina G</name>
      </author>
      <author>
        <name>Shaner, Nathan C</name>
        <uri>https://orcid.org/0000-0002-0148-0769</uri>
      </author>
      <author>
        <name>Saab, Carl Y</name>
      </author>
      <author>
        <name>Gomez-Ramirez, Manuel</name>
      </author>
      <author>
        <name>Borton, David A</name>
      </author>
      <author>
        <name>Moore, Christopher I</name>
      </author>
    </item>
    <item>
      <title>CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model</title>
      <link>https://escholarship.org/uc/item/3089p21v</link>
      <description>BACKGROUND: Natural killer (NK) cells are key effector cells of antitumor immunity. However, tumors can acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying mechanisms that mediate this resistance enables us to define approaches to improve immune-mediate antitumor activity. In previous studies from our group, a genome-wide CRISPR-Cas9 screen identified Charged Multivesicular Body Protein 2A (&lt;i&gt;CHMP2A&lt;/i&gt;) as a novel mechanism that mediates tumor intrinsic resistance to NK cell activity.
METHODS: Here, we use an immunocompetent mouse model to demonstrate that CHMP2A serves as a targetable regulator of not only NK cell-mediated immunity but also other immune cell populations. Using the recently characterized murine 4MOSC model system, a syngeneic, tobacco-signature murine head and neck squamous cell carcinoma model, we deleted mCHMP2A using CRISPR/Cas9-mediated knock-out (KO), following orthotopic transplantation into immunocompetent hosts.
RESULTS:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3089p21v</guid>
      <pubDate>Thu, 23 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Yun, Jiyoung</name>
      </author>
      <author>
        <name>Saddawi-Konefka, Robert</name>
        <uri>https://orcid.org/0000-0002-9936-1695</uri>
      </author>
      <author>
        <name>Goldenson, Benjamin</name>
      </author>
      <author>
        <name>Al-Msari, Riyam</name>
      </author>
      <author>
        <name>Bernareggi, Davide</name>
      </author>
      <author>
        <name>Thangaraj, Jaya L</name>
      </author>
      <author>
        <name>Tang, Shiqi</name>
      </author>
      <author>
        <name>Patel, Sonam H</name>
      </author>
      <author>
        <name>Luna, Sarah M</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Kaufman, Dan</name>
        <uri>https://orcid.org/0000-0002-2003-2494</uri>
      </author>
    </item>
    <item>
      <title>Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A2 (PNPLA9) and its role in neurodegenerative diseases</title>
      <link>https://escholarship.org/uc/item/7150p4d2</link>
      <description>Glycerophospholipids are major components of cell membranes and consist of a glycerol backbone esterified with one of over 30 unique fatty acids at each of the sn-1 and sn-2 positions. In addition, in some human cells and tissues as much as 20% of the glycerophospholipids contain a fatty alcohol rather than an ester in the sn-1 position, although it can also occur in the sn-2 position. The sn-3 position of the glycerol backbone contains a phosphodiester bond linked to one of more than 10 unique polar head-groups. Hence, humans contain thousands of unique individual molecular species of phospholipids given the heterogeneity of the sn-1 and sn-2 linkage and carbon chains and the sn-3 polar groups. Phospholipase A&lt;sub&gt;2&lt;/sub&gt; (PLA&lt;sub&gt;2&lt;/sub&gt;) is a superfamily of enzymes that hydrolyze the sn-2 fatty acyl chain resulting in lyso-phospholipids and free fatty acids that then undergo further metabolism. PLA&lt;sub&gt;2&lt;/sub&gt;'s play a critical role in lipid-mediated biological responses and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7150p4d2</guid>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hayashi, Daiki</name>
      </author>
      <author>
        <name>Dennis, Edward A</name>
        <uri>https://orcid.org/0000-0003-3738-3140</uri>
      </author>
    </item>
    <item>
      <title>Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling</title>
      <link>https://escholarship.org/uc/item/5k61r8hk</link>
      <description>Many of the fundamental concepts of signal transduction and kinase activity are attributed to the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A. PKA is one of the best-studied kinases in human biology, with emphasis in biochemistry and biophysics, all the way to metabolism, hormone action, and gene expression regulation. It is surprising, however, that our understanding of PKA's role in disease is largely underappreciated. Although genetic mutations in the PKA holoenzyme are known to cause diseases such as Carney complex, Cushing syndrome, and acrodysostosis, the story largely stops there. With the recent explosion of genomic medicine, we can finally appreciate the broader role of the G&lt;i&gt;α&lt;/i&gt;s-PKA pathway in disease, with contributions from aberrant functioning G proteins and G protein-coupled receptors, as well as multiple alterations in other pathway components and negative regulators. Together, these represent a broad family of diseases...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5k61r8hk</guid>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ramms, Dana J</name>
      </author>
      <author>
        <name>Raimondi, Francesco</name>
      </author>
      <author>
        <name>Arang, Nadia</name>
      </author>
      <author>
        <name>Herberg, Friedrich W</name>
      </author>
      <author>
        <name>Taylor, Susan S</name>
      </author>
      <author>
        <name>Gutkind, J Silvio</name>
        <uri>https://orcid.org/0000-0002-5150-4482</uri>
      </author>
      <author>
        <name>Schulte, Gunnar</name>
      </author>
    </item>
    <item>
      <title>Enhancing Target Tissue Levels and Diminishing Plasma Clearance of Ionizing Zwitterionic Antidotes in Organophosphate Exposures</title>
      <link>https://escholarship.org/uc/item/51h4h7b5</link>
      <description>Inhibition of acetylcholinesterase (AChE) by certain organophosphates (OPs) can be life-threatening and requires reactivating antidote accessibility to the peripheral and central nervous systems to reverse symptoms and enhance survival parameters. In considering dosing requirements for oxime antidotes in OP exposures that inactivate AChE, clearance of proton ionizable, zwitterionic antidotes is rapid and proceeds with largely the parent antidotal compound being cleared by renal transporters. Such transporters may also control disposition between target tissues and plasma as well as overall elimination from the body. An ideal small-molecule antidote should access and be retained in primary target tissues-central nervous system (brain), skeletal muscle, and peripheral autonomic sites-for sufficient periods to reactivate AChE and prevent acute toxicity. We show here that we can markedly prolong the antidotal activity of zwitterionic antidotes by inhibiting P-glycoprotein (P-gp) transporters...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/51h4h7b5</guid>
      <pubDate>Fri, 10 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Shyong, Yan-Jye</name>
      </author>
      <author>
        <name>Sepulveda, Yadira</name>
      </author>
      <author>
        <name>Garcia, Arnold</name>
      </author>
      <author>
        <name>Samskey, Nathan M</name>
      </author>
      <author>
        <name>Radic, Zoran</name>
        <uri>https://orcid.org/0000-0003-0806-3869</uri>
      </author>
      <author>
        <name>Sit, Rakesh K</name>
      </author>
      <author>
        <name>Sharpless, K Barry</name>
      </author>
      <author>
        <name>Momper, Jeremiah D</name>
      </author>
      <author>
        <name>Taylor, Palmer</name>
      </author>
    </item>
    <item>
      <title>Scaling the cellular frontier: Mechanobiology, tissue dynamics and function</title>
      <link>https://escholarship.org/uc/item/9h8838pf</link>
      <description>Scaling the cellular frontier: Mechanobiology, tissue dynamics and function</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9h8838pf</guid>
      <pubDate>Thu, 9 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Scita, Giorgio</name>
      </author>
    </item>
    <item>
      <title>Early career Latinas in STEM: Challenges and solutions</title>
      <link>https://escholarship.org/uc/item/3rm3m38c</link>
      <description>Mexican, Puerto Rican, and Central American Ancestry (MPRCA) individuals represent 82% of US Latinos. An intergenerational group of MPRCA women and allies met to discuss persistent underrepresentation of MPRCA women in STEM, identifying multi-level challenges and solutions. Implementation of these solutions is important and will benefit MPRCA women and the entire academic community.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3rm3m38c</guid>
      <pubDate>Thu, 9 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Werner Washburne, Maggie</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Zambrana, Ruth Enid</name>
      </author>
      <author>
        <name>Zavala, Maria Elena</name>
      </author>
      <author>
        <name>Martinic, Alice</name>
      </author>
      <author>
        <name>Riestra, Angelica</name>
      </author>
      <author>
        <name>Delgado, Tracie</name>
      </author>
      <author>
        <name>Edwards, Staci</name>
      </author>
      <author>
        <name>Escobar, Thelma</name>
      </author>
      <author>
        <name>Jamison-McClung, Denneal</name>
      </author>
      <author>
        <name>Vazquez, Mariel</name>
        <uri>https://orcid.org/0000-0001-8328-6806</uri>
      </author>
      <author>
        <name>Vera, Iset</name>
      </author>
      <author>
        <name>Guerra, Michelle</name>
      </author>
      <author>
        <name>Marinez, Diana I</name>
      </author>
      <author>
        <name>Gonzalez, Elma</name>
      </author>
      <author>
        <name>Rodriguez, Raymond L</name>
        <uri>https://orcid.org/0000-0002-6105-2571</uri>
      </author>
    </item>
    <item>
      <title>Diversity, Equity and Inclusion in the Laboratory: Strategies to Enhance Inclusive Laboratory Culture</title>
      <link>https://escholarship.org/uc/item/12d00395</link>
      <description>Building a diverse laboratory that is equitable is critical for the retention of talent and the growth of trainees professionally and personally. Here, we outline several strategies including enhancing understanding of cultural competency and humility, establishing laboratory values, and developing equitable laboratory structures to create an inclusive laboratory environment to enable trainees to achieve their highest success.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/12d00395</guid>
      <pubDate>Thu, 9 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Marshall, Andrea G</name>
      </author>
      <author>
        <name>Vue, Zer</name>
      </author>
      <author>
        <name>Beasley, Heather K</name>
      </author>
      <author>
        <name>Neikirk, Kit</name>
      </author>
      <author>
        <name>Stephens, Dominique</name>
      </author>
      <author>
        <name>Wanjalla, Celestine N</name>
      </author>
      <author>
        <name>Damo, Steven M</name>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Rodriguez-Aliaga, Piere</name>
      </author>
      <author>
        <name>Headley, Colwyn Ansel</name>
      </author>
      <author>
        <name>Shuler, Haysetta</name>
      </author>
      <author>
        <name>Liu, Kaihua</name>
      </author>
      <author>
        <name>Smith, Nathan</name>
      </author>
      <author>
        <name>Garza-Lopez, Edgar</name>
      </author>
      <author>
        <name>Barongan, Taylor</name>
      </author>
      <author>
        <name>Scudese, Estevão</name>
      </author>
      <author>
        <name>Spencer, Elsie</name>
      </author>
      <author>
        <name>Heemstra, Jennifer</name>
      </author>
      <author>
        <name>Vazquez, Arnaldo Diaz</name>
      </author>
      <author>
        <name>Murray, Sandra A</name>
      </author>
      <author>
        <name>Hinton, Antentor</name>
      </author>
    </item>
    <item>
      <title>Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial</title>
      <link>https://escholarship.org/uc/item/4v16j7m0</link>
      <description>IntroductionRetrospective studies report that angiotensin-converting enzyme inhibitors (ACEIs) may reduce the severity of COVID-19, but prospective data on de&amp;nbsp;novo treatment with ACEIs are limited. The RAMIC trial was a randomized, multicenter, placebo-controlled, double-blind, allocation-concealed clinical trial to examine the efficacy of de&amp;nbsp;novo ramipril versus placebo for the treatment of COVID-19.MethodsEligible participants were aged 18&amp;nbsp;years and older with a confirmed diagnosis of SARS-CoV-2 infection, recruited from urgent care clinics, emergency departments, and hospital inpatient wards at eight sites in the USA. Participants were randomly assigned to daily ramipril 2.5&amp;nbsp;mg or placebo orally in a 2:1 ratio, using permuted block randomization. Analyses were conducted on an intention-to-treat basis. The primary outcome was a composite of mortality, intensive care unit (ICU) admission, or invasive mechanical ventilation by day&amp;nbsp;14.ResultsBetween 27&amp;nbsp;May...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4v16j7m0</guid>
      <pubDate>Tue, 7 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Huang, Daniel Q</name>
      </author>
      <author>
        <name>Ajmera, Veeral</name>
      </author>
      <author>
        <name>Tomaszewski, Christian</name>
      </author>
      <author>
        <name>LaFree, Andrew</name>
        <uri>https://orcid.org/0000-0002-4817-1664</uri>
      </author>
      <author>
        <name>Bettencourt, Ricki</name>
      </author>
      <author>
        <name>Thompson, Wesley K</name>
      </author>
      <author>
        <name>Smith, Davey M</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
      <author>
        <name>Malhotra, Atul</name>
      </author>
      <author>
        <name>Mehta, Ravindra L</name>
      </author>
      <author>
        <name>Tolia, Vaishal</name>
      </author>
      <author>
        <name>Yin, Jeffrey</name>
      </author>
      <author>
        <name>Insel, Paul A</name>
        <uri>https://orcid.org/0000-0001-8521-5315</uri>
      </author>
      <author>
        <name>Leachman, Stone</name>
      </author>
      <author>
        <name>Jung, Jinho</name>
      </author>
      <author>
        <name>Collier, Summer</name>
      </author>
      <author>
        <name>Richards, Lisa</name>
      </author>
      <author>
        <name>Woods, Kristin</name>
      </author>
      <author>
        <name>Amangurbanova, Maral</name>
        <uri>https://orcid.org/0000-0002-3799-3857</uri>
      </author>
      <author>
        <name>Bhatt, Archana</name>
      </author>
      <author>
        <name>Zhang, Xinlian</name>
      </author>
      <author>
        <name>Penciu, Oana M</name>
      </author>
      <author>
        <name>Zarich, Stuart</name>
      </author>
      <author>
        <name>Retta, Tamrat</name>
      </author>
      <author>
        <name>Harkins, Michelle S</name>
      </author>
      <author>
        <name>Teixeira, J Pedro</name>
      </author>
      <author>
        <name>Chinnock, Brian</name>
      </author>
      <author>
        <name>Utay, Netanya S</name>
      </author>
      <author>
        <name>Lake, Jordan E</name>
      </author>
      <author>
        <name>Loomba, Rohit</name>
        <uri>https://orcid.org/0000-0002-4845-9991</uri>
      </author>
    </item>
    <item>
      <title>The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman</title>
      <link>https://escholarship.org/uc/item/4st553gt</link>
      <description>The recent, unfortunate death of Alfred G. ("Al") Gilman, M.D., Ph.D., represents a sad signpost for an era spanning over 40 years in molecular pharmacology. Gilman's discoveries, influence, and persona were dominant forces in research and training in pharmacology. Here, we review the progression of ideas and knowledge that spawned early work by Gilman and collaborators (among them, one of the authors) and later efforts (including those of the other author) that have recently yielded a comprehensive and precise structural understanding of fundamental topics in pharmacology: the binding of ligands to G protein-coupled receptors (GPCRs) and the interaction of GPCRs with heterotrimeric G proteins and effector molecules. Those data provide new and important insights into the molecular basis that underlies affinity and efficacy, two of the most important features of drug action, which represent the latest chapter in the saga that Al Gilman's work helped launch.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4st553gt</guid>
      <pubDate>Mon, 29 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sunahara, Roger K</name>
      </author>
      <author>
        <name>Insel, Paul A</name>
      </author>
    </item>
    <item>
      <title>Kinetic trapping organizes actin filaments within liquid-like protein droplets</title>
      <link>https://escholarship.org/uc/item/75x4m84n</link>
      <description>Several actin-binding proteins (ABPs) phase separate to form condensates capable of curating the actin network shapes. Here, we use computational modeling to understand the principles of actin network organization within VASP condensate droplets. Our simulations reveal that the different actin shapes, namely shells, rings, and mixture states are highly dependent on the kinetics of VASP-actin interactions, suggesting that they arise from kinetic trapping. Specifically, we show that reducing the residence time of VASP on actin filaments reduces degree of bundling, thereby promoting assembly of shells rather than rings. We validate the model predictions experimentally using a VASP-mutant with decreased bundling capability. Finally, we investigate the ring opening within deformed droplets and found that the sphere-to-ellipsoid transition is favored under a wide range of filament lengths while the ellipsoid-to-rod transition is only permitted when filaments have a specific range of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/75x4m84n</guid>
      <pubDate>Sat, 27 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chandrasekaran, Aravind</name>
      </author>
      <author>
        <name>Graham, Kristin</name>
      </author>
      <author>
        <name>Stachowiak, Jeanne C</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
      </author>
    </item>
    <item>
      <title>Engineering luminopsins with improved coupling efficiencies</title>
      <link>https://escholarship.org/uc/item/63h3f589</link>
      <description>Significance: Luminopsins (LMOs) are bioluminescent-optogenetic tools with a luciferase fused to an opsin that allow bimodal control of neurons by providing both optogenetic and chemogenetic access. Determining which design features contribute to the efficacy of LMOs will be beneficial for further improving LMOs for use in research.
Aim: We investigated the relative impact of luciferase brightness, opsin sensitivity, pairing of emission and absorption wavelength, and arrangement of moieties on the function of LMOs.
Approach: We quantified efficacy of LMOs through whole cell patch clamp recordings in HEK293 cells by determining coupling efficiency, the percentage of maximum LED induced photocurrent achieved with bioluminescent activation of an opsin. We confirmed key results by multielectrode array recordings in primary neurons.
Results: Luciferase brightness and opsin sensitivity had the most impact on the efficacy of LMOs, and N-terminal fusions of luciferases to opsins performed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/63h3f589</guid>
      <pubDate>Sat, 27 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Slaviero, Ashley N</name>
      </author>
      <author>
        <name>Gorantla, Nipun</name>
      </author>
      <author>
        <name>Simkins, Jacob</name>
      </author>
      <author>
        <name>Crespo, Emmanuel L</name>
      </author>
      <author>
        <name>Ikefuama, Ebenezer C</name>
      </author>
      <author>
        <name>Tree, Maya O</name>
      </author>
      <author>
        <name>Prakash, Mansi</name>
      </author>
      <author>
        <name>Björefeldt, Andreas</name>
      </author>
      <author>
        <name>Barnett, Lauren M</name>
      </author>
      <author>
        <name>Lambert, Gerard G</name>
      </author>
      <author>
        <name>Lipscombe, Diane</name>
      </author>
      <author>
        <name>Moore, Christopher I</name>
      </author>
      <author>
        <name>Shaner, Nathan C</name>
        <uri>https://orcid.org/0000-0002-0148-0769</uri>
      </author>
      <author>
        <name>Hochgeschwender, Ute</name>
      </author>
    </item>
  </channel>
</rss>
